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Abstract 
Incidence of Staphylococcus species in bovine milk; their antimicrobial sensitivity in 
selected antibiotics and Usnea barbata lichen extracts 
By 
Emrobowansan Monday IDAMOKORO 
This study was done in order to assess the incidence of Staphylococcus species from milk of 
cows with subclinical mastitis and their antimicrobial sensitivity in some selected antibiotics 
and Usnea barbata lichen extracts. The study was conducted in two different commercial 
dairy farms. Staphylococcus species isolates were identified using several biochemical tests 
which included Gram’s staining test, catalase test and oxidase test. A commercial API® staph 
kit (bioMerieux, France) was used to confirm the bacterial organisms to their species level. 
The antimicrobial sensitivity of individual species was determined according to the Clinical 
Laboratory Standard Institute (CLSI) for the selected antibiotics. Agar well diffusion method 
and the broth micro-dilution technique were used to determine the sensitivity of 
Staphylococcus species in U. barbata extracts. A total of 467 milk samples were screened for 
bacterial identification from the two farms. Fifteen different Staphylococcus species isolates 
were identified from all milk samples that were examined. The most frequently isolated 
species included Staphylococcus xylosus (54.34%), Staphylococcus hominis (24.78%), 
Staphylococcus aureus (16.38%), Staphylococcus saprophyticus (16.12%) and 
Staphylococcus haemolyticus (11.63%). Most Staphylococcus species were resistant to 
Penicillin (75.35%), Nalidixic acid (72.55%) and Ampicillin (63%). Furthermore, the 
bacterial sensitivity evaluation of U. barbata lichen extracted with methanol and ethyl-acetate 
against selected Staphylococcus species isolates showed 92.31% and 53.85% susceptibility, 
respectively. The minimum inhibitory concentration (MIC) of the methanol and ethyl-acetate 
extracts ranged between 0.0390 to 10 mg/ml. There was a relatively high incidence of 
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Staphylococcus species identified in milk of cows with subclinical mastitis from both farms. 
Conversely, Staphylococcus species isolates were resistant to antibiotics (mostly penicillin 
and ampicillin) commonly used in the farms. Furthermore, the study investigated the 
antimicrobial sensitivity of U. barbata extract in-vitro which may validate its use in 
traditional medicine for treatment of cows with mastitis.  
Key words: Antibiotic resistance, Staphylococcus species, subclinical mastitis, susceptibility, 
traditional medicine. 
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Chapter 1: Introduction 
A major udder health problem of cows is mastitis disease which could lead to the 
inflammation of cow udder in severe cases (Awale et al., 2012). It is a livestock disease that 
is spread among dairy herds and currently known to cause a serious challenge in the dairy 
sector nationwide (Gill et al., 2006). Several micro-organisms of common bacteria, fungi, 
mycoplasmas and algae cause mastitis in cows (Batavani et al., 2007). Major mastitis causing 
organisms include Staphylococcus aureus, Streptococcus uberis, Streptococcus dysgalactiae 
and Streptococcus bovis (Pitkala et al., 2004; Tenhagen et al., 2006). They make the milk 
produced by lactating cows to be high in bacteria count and of low quality (Barbano et al., 
2006; Oliver, 2012). Cows with mastitis have reduced milk yield, which in turn reduces 
farmers’ profits (Halasa et al., 2009; Ampe et al., 2012). The disease is one of the most 
expensive diseases that affect dairy farms all over the world (Dufour et al., 2012). The 
financial loss suffered by farmers as a result of mastitis disease alone could be up to an 
estimate of about 70% of all avoidable losses incurred during milk production (Sumathi et al., 
2008). 
 
Staphylococcus species are the bacteria that are frequently isolated from milk samples of 
cows with subclinical and clinical mastitis (Pitkala et al., 2004; Tenhagen et al., 2006). They 
are grouped as Coagulase Negative Staphylococci (CNS) and Coagulase Positive 
Staphylococci (CPS) and have been linked with the cause of both clinical and subclinical 
mastitis (De Viegher et al., 2003; Taponen et al., 2006). Common species of CNS include 
Staphylococcus Chromogenes, Staphylococcus simulans, Staphylococcus xylosus, 
Staphylococcus epidermidis, Staphylococus hyicus and Staphylococcus haemolyticus 
(Thorberg et al., 2009) while examples of CPS include Staphylococcus aureus and 
Staphylococcus hyicus (Awale et al., 2012). Lately, CNS has evolved in dairy farms as an 
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emerging mastitis causing organism (Simojoki et al., 2011). According to Petzer et al. 
(2009), CNS is a significant mastitis causing organism in South Africa. They are often 
isolated from cow udder teats, skin, udder duct and milk of cows that show clinical and 
subclinical signs (De Viegher et al., 2003; Taponen et al., 2006). 
 
Most cases of CNS infections are subclinical and they lead to high culling rates, cow 
replacement and reduction in farmers’ profits due to poor quality of milk (Sandgren et al., 
2008). Raw milk can be contaminated by infected animals during milking (Kousta et al., 
2010).  Poorly managed milking machines, improper farm practices during milking could 
also cause high risk of infections among cows by mastitis pathogens (Philip et al., 2011). 
Presently, most dairy farms are becoming antibiotic dependant so as to improve cow 
productivity (Walther et al., 2008; Mc Kenna, 2011). Mastitis disease in cows is one of the 
sole reasons for the use of antibiotics in dairy farms (Awandkar et al., 2009). Antibiotics are 
used as therapeutics, growth promoters and prophylactics in livestock production (Sawant et 
al., 2005). However, mastitis pathogens are developing resistance to antibiotic drugs (Febler 
et al., 2010). This is raising a serious alarm as the rate of resistance is increasing yearly in 
various countries of the world (WHO, 2000). The complex inter relationship among 
antibiotics, bacteria and the immediate surroundings of animals gave rise to the evolution and 
spread of antibiotic resistance in farms (Mc Dermott et al., 2002; Taponen and Pyorala, 
2009). 
 
Some of the antimicrobial agents used in the treatment of mastitis disease include beta- 
lactams, macrolides and lincosamides. Conversely, several Staphylococcus species including 
CPS and CNS isolated from bovine milk are currently becoming resistant to these 
antimicrobial agents (Gentilini et al., 2002; Pitkala et al., 2004; Luthje et al., 2006; Sawant et 
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al., 2009); thus, increasing the search for other effective options and/or antibiotics to control 
and treat cows with mastitis (Pieterse and Todorov, 2010). A lot of small scale farmers 
currently use other cheaper antibiotic agents (plants) as an alternative against the 
conventional antibiotic agents to treat their animals (Masika et al., 2000). Africa, as a 
continent is in the lead in the use of plants for treating both humans and animals (Ndip et al., 
2007). One of the plants that have been investigated to be active against mastitis causing 
pathogens is U. barbata (Rankovic et al., 2012). Usnea barbata lichen, locally known as old 
man’s beard are epiphytes that grow on trees, rocks and soils with low fertility (Vrablikova et 
al., 2006).  
 
The U. barbata extracts have been shown to possess inhibitory activity against most Gram 
positive bacteria and some Gram negative bacteria (Madamombe and Afolayan, 2003; 
Rankovic et al., 2012). To our knowledge, information on the use of the lichen extracts 
against the selected Staphylococcus species in the current study is sparse. More so, Petzer et 
al. (2009) in their study reported that CNS together with other Staphylococcus species 
including S. aureus is increasingly becoming a significant mastitis causing pathogen in South 
Africa. 
 
1.1.Justification 
Udder health disease caused by mastitis pose a severe threat in the dairy sector (Bradley, 
2002). There is an emergence of several Staphylococcus species especially CNS linked with 
the cause of mastitis on a daily basis in dairy farms all over the world. Increase in the rate of 
antimicrobial resistance by Staphylococcus species to antibiotic drugs is also becoming a 
huge global concern. Prevalence of Staphylococcus species bacteria among dairy herd in a 
farm, may lead to intra mammary infections among the herd, high culling rate and increase in 
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milk somatic cell counts (Barbano et al., 2006). The study by Petzer et al. (2009) gave a 
general prevalence of S. aureus and CNS isolated in milk samples from dairy herds over a 
period of eleven years in South Africa. Yet, not much information about the incidence of 
CNS at the species level and their reactions to antibiotics has been reported in South Africa. 
There is need to identify the specific individual CNS (not as a group) in bovine milk and their 
antimicrobial sensitivity pattern to conventional antibiotics. Also, by extension it is essential 
to evaluate the sensitivity of the selected Staphylococcus species bacteria in U. barbata 
extracts. This is because the lichen is a commonly used medicinal plant for the treatment of 
mastitic cows by local farmers in the Eastern Cape Province of South Africa. The findings 
from the current study may help in getting a better understanding about the prevalence of the 
bacteria species in dairy farms and their response to antibiotics. Most dairy farmers in the 
Eastern Cape Province of South Africa do not engage in antimicrobial susceptibility testing 
as part of their routine practices. The result obtained from the current study may give useful 
information to farmers on the importance of antimicrobial susceptibility testing as part of 
their routine practices in their farms.  In addition, the information on the in-vitro outcome of 
U. barbata inhibitory activities against some isolated Staphylococcus species could give a 
cheaper alternative as an antimicrobial agent in traditional medicine.   
 
1.2. Objectives 
The broad objective of the study was to isolate and identify different Staphylococcus species 
from bovine milk and to establish antimicrobial sensitivity pattern. 
 
The specific objectives were to: 
1. Determine the incidence of Staphylococcus species in bovine milk from two farms 
over a period of time. 
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2. Determine the antimicrobial sensitivity of some Staphylococcus species isolated from 
bovine milk; and 
3. Validate the in vitro inhibitory activity of U. barbata extracts from methanol and 
ethyl-acetate against some selected bovine Staphylococcus species. 
 
 
1.3 Hypothesis 
1. There is no incidence of different Staphylococcus species in commercial dairy farms.  
2. The antimicrobial sensitivity pattern of Staphylococcus species to conventional antibiotics 
is the same. 
3. Extracts from Usnea barbata lichen do not inhibit the growth of Staphylococcus species 
in-vitro. 
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Chapter 2: Literature review 
2.1. Introduction 
Mastitis disease in dairy herds negatively affects quality of milk (Barbano et al., 2006). High 
incidence rate of mastitis hampers the welfare of cows (Kemp et al., 2008; Hogeveen et al., 
2011; Sundrum, 2012). Apart from Staphylococcus aureus several other staphylococci are 
reported to cause mastitis. In many countries globally, CNS have gained recognition (Pyorala 
and Taponen, 2009). This is because they cause mastitis in cows (Taponen et al., 2007). They 
are often isolated from milk of cows causing intra mammary infection (Pyorala and Taponen, 
2009). The use of antimicrobials for the treatment of Staphylococcus species has been 
reported (Moon et al., 2007; Bengtsson et al., 2009; Frey et al; 2013). Despite this, they have 
also been several instances of these bacteria species becoming resistant to the antimicrobials 
used against them (Taponen et al., 2009).  
 
In the case of CNS, they are often treated as a group even though they vary in both their 
phenotypic and genotypic characteristics (Layer et al., 2007; Onni et al., 2010). For easy 
identification of the different species of CNS, several methods including API staph 32 ID and 
the Staph Zym test have been adopted. The prevalence at the species level is necessary so as 
to ascertain the impact that they play in causing mastitis in dairy farms (Pyorala and Taponen, 
2009). This chapter gives a review of the incidence of Staphylococcus species (especially 
CNS) in cows with subclinical mastitis and their antimicrobial susceptibility pattern in 
antibiotics. 
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2.2. Staphylococcus species as mastitis pathogens in dairy farms 
The issue of mastitis is a serious challenge despite strategies put in place to control the 
prevalence in dairy farm environment. The resultant effect of mastitis infection is poor 
performance of cows in terms of milk production, milk quality and increased treatment cost 
of affected cows (Hunderra et al., 2005). Mastitis is subclinical in most cases and it causes 
udder health problems. Of late, CNS has been shown to cause subclinical mastitis and in 
some other cases they cause a mild form of clinical mastitis (Taponen et al., 2009). Their 
involvement in causing udder health problems is a concern to farmers, veterinarians and 
researchers all over the world.  
 
Some bacteria pathogens are said to be major causes of mastitis. Others are referred to as 
minor pathogens because they have insignificant or no impact in causing mastitis in cows. 
Among bacteria pathogens grouped as minor pathogens is CNS. But recently, several reports 
have indicated that they are involved in mastitis infection (Pitkala et al., 2004; Rajala-Schultz 
et al., 2004). Staphylococcus epidermidis, Staphylococcus simulans, Staphylococcus 
chromogenes, Staphylococcus xylosus and Staphylococcus haemolyticus are some examples 
of CNS pathogens (Aarestrup et al., 1999; Taponen et al., 2006). Major mastitis pathogens 
include Streptococci agalactiae, Streptococcus dysgalactiae, Escherichia coli, Streptococcus 
uberius and Staphylococcus aureus (Petersson-Wolfe et al., 2010; Philip et al., 2011). Factors 
such as mammary gland physiology, health of cow, management practices, cow immunity 
and dairy farm environment have been linked with the incidence of mastitis causing 
organisms (Waage et al., 2000; Zadoks et al., 2002; Oviedo-Boyso et al., 2007). 
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2.3. Species of CNS: infection pathogenesis and prevalence  
Staphylococcus species is a group of bacteria that is classified based on their ability to 
coagulate blood plasma. They are grouped as coagulase positive staphylococci (CPS) on one 
hand and coagulase negative staphylococci (CNS) on the other hand. An estimate of 50 
Staphylococcus species and subspecies has been characterized under this group (Pyorala and 
Taponen, 2009). Mammary gland of cows becomes swollen in critical cases as a result of 
infection caused by bacterial pathogens that are associated with mastitis (Dufour et al., 2012). 
Though, CNS are indicted to be pathogens of less importance in bovine mastitis, they play a 
relevant role in intra mammary infection leading to mastitis in cows (Pyorala and Taponen, 
2009). Intra mammary infection is caused mostly by bacteria including CNS found in 
subclinical mastitis (Djabri et al., 2002). Isolation of CNS from cows with subclinical and 
clinical mastitis has been reported (Jorun, 1991; Myllvs, 1995; Tenhagen et al., 2006; 
Koivula et al., 2007). 
 
The ability of CNS to cause mastitis warrant that they should be studied as major mastitis 
causing pathogens and not just as minor pathogens of cow skin micro flora (Taponen et al., 
2009). According to Andersen et al. (2010), researchers are yet to agree on the right 
definition for intra mammary infection caused by different bacteria on cows that result in 
mastitis. Information on the effect of CNS in relation to mastitis is rare (Thorberg, 2008).  
 
Infection of cows by CNS to cause mastitis is usually at different stages of lactation. 
Primiparous cows are infected with CNS at their early stage of lactation whereas multiparous 
cows are infected at their late stage of lactation (Grohn et al., 2004; Taponen et al., 2007). 
The CNS species that infect heifers are not the same as those that infect cows; infection of 
cows by CNS varies based on their age (Pyorala and Taponen, 2009). Among the frequently 
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isolated CNS species from mastitis are Staphylococcus chromogenes, Staphylococcus 
simulans, Staphylococcus hyicus, Staphylococcus xylosus, Staphylococcus haemolyticus and 
Staphylococcus epidermidis (Trinidad et al., 1990; Matthews et al., 1992; Thorberg et al., 
2006; Frey et al., 2013). Persistent intra mammary infections by CNS continue for a long 
period of time throughout lactation when cows are not detected and treated (Aarestrup et al., 
1999; Oliver et al., 2003; Gillespie et al., 2009). 
 
Mastitis prevalence and spread caused by CNS varies from country to country. Change in 
season also contributes to the proportion of CNS pathogens that causes mastitis (Makovec 
and Ruegg, 2003; Osteras et al., 2006). Type of housing system, level of farm production, 
parity, lactation stage, variation in sampling techniques and method of species identification 
are other factors that influence the prevalence of mastitis caused by Staphylococcus species 
(Thorberg, 2008). In most cases CNS occurs more in subclinical mastitis than in clinical 
mastitis (Pyorala and Taponen, 2009).  Lack of awareness by farmers on the potential of CNS 
to cause mastitis may be reason for mastitis problem; and information on the prevalence of 
CNS is helpful in the control of mastitis spread caused by CNS (Pyorala and Taponen, 2009). 
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Table 2. 1 Proportion of CNS isolated from subclinical mastitis in different countries as 
reported by literature 
 
Country of origin % Source 
Germany 35 Tenhagen et al.(2006) 
USA (Tennessee) 28(Herds with high SCC) 
12-41 (Herd prevalence) 
Roberson et al.(2006) 
Netherland 6 Poelarends et al. (2001) 
Estonia 16 Haltia et al. (2006) 
Canada and USA 15 Dingwell et al. (2004) 
France 13.7 Botrel et al. (2010) 
Finland 24-50 Pitkala et al. (2004); Koivula 
et al. (2007) 
Norway 16 Osteras et al. (2006) 
South Africa 61 Petzer et al. (2009) 
SCC= Somatic cell count 
 
Isolation of CNS from cows with clinical mastitis has also been reported in some countries. 
Seasons determine the prevalence of CNS mastitis in different countries. Study by Koivula et 
al. (2007) in Finland and Osteras et al. (2006) in Norway indicated that there is seasonal 
influence on the occurrence of CNS mastitis in cows. In the case of intra mammary infection 
in dairy herds, there is higher prevalence of CNS in heifers when compared with older cows 
(Sampimon et al., 2009a). The knowledge of CNS distribution within specific regions and 
their species-specific prevalence will help to combat the issue of mastitis related to CNS. 
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Table 2. 2 Proportion of CNS isolated from clinical mastitis from different countries as 
reported by literature 
 
Country of origin % source 
Wisconsin (USA) 17.5 Makovec and Ruegg, (2003) 
Israel 9 Shpigel et al. (1998) 
Finland 18 Koivula et al., (2007) 
 
2.4. Seasonal variation of CNS pathogen  
In the dairy industry the rate of mastitis incidence in a dairy herd is one of the parameters 
used for determining udder health (Olde-Riekerink et al., 2007). Individual cow and bulk 
tank somatic cell counts are other parameters used to determine udder health (Olde- 
Riekerink et al., 2007). Incidence rate of mastitis is affected by season (Morse et al., 1988; 
Olde- Riekerink et al., 2007). Cows are more prone to high incidences of clinical mastitis in 
the fall (December) than in summer (Olde-Riekerink et al., 2007). Inter-play of specific 
mastitis disease causing organisms in cows in relation to season also exist (Osteras et al., 
2006). High prevalence of Streptococcus dysgalactiae and CNS was reported in winter than 
in other seasons (Osteras et al., 2006). According to Hogan et al. (1989), Makovec and 
Ruegg (2003) the incidence rate of mastitis was high for Streptococci and coliforms in 
summer. Conversely, mastitis prevalence caused by Staphylococcus aureus and 
Streptococcus uberis was high in summer compared to other seasons (Osteras et al., 2006). 
The adaptive and persistent nature of some Staphylococcus species to the mammary glands of 
cows is a reason for variation in the incidence of the bacteria in milk (Piesssens et al., 2012). 
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2.5. Colonization of CNS species on cow udder quarters and their protective role 
Coagulase negative staphylococci (CNS) are minor pathogens having little or no impact in 
causing mastitis in cows (Pyorala and Taponen, 2009). Recent studies indicated that some 
CNS species show inhibitory attributes against major mastitis causing pathogens thereby 
acting to protect to cow udders against potential mastitis causing pathogenic species (Reyher 
et al., 2012a). Staphylococcus chromogenes is an example of CNS that inhibits other major 
mastitis causing organisms from infecting the udder of cows (De Vliegher et al., 2004). 
According to some literatures, there are contradictory reports as to whether CNS actually play 
a protective role or increase the risk of infection on udder quarters of cows (Green et al., 
2002; Reyher et al., 2012b). In a report by Zadoks et al. (2001), CNS species do not show a 
protective effect against udder quarters of cows and they also do not expose them to risk of 
infection by major mastitis pathogens.  Matthews et al. (1990) and Lam et al. (1997) 
indicated that cow quarters that were infected with CNS are likely to show resistance to any 
further infections by Staphylococcus aureus and Streptococci species. 
 
An in-vitro study carried out by De Vliegher et al. (2004) showed the inhibition of 
Staphylococcus aureus, Streptococcus uberis, and Streptococcus dysgalactiae by 
Staphylococcus chromogenes. Dos Santos Nascimento et al. (2005) also reported the 
inhibition of Staphylococcus agalactiae a major mastitis pathogen by some strains of CNS. 
The production of antibacterial peptides by CNS is a possible mechanism involved in the 
inhibition of major mastitis (Dos Santos Nascimento et al., 2005; Sawant et al., 2009). In the 
study of De Vliegher et al. (2004), Staphylococcus chromogenes secreted substances that 
inhibit the growth of Staphylococcus aureus and other streptococci. Contradicting studies by 
Compton et al. (2007) and Parker et al. (2007) indicated that CNS do not show any protective 
effect on udder quarters of cows against major mastitis. In order to properly understand the 
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protective and risk factor effect of CNS bacteria on udder quarter of cows factors such as age, 
lactation stage, immunity level, anatomy of cows are to be considered (Reyher et al ., 2012b).  
 
2.6. Antimicrobial resistance by bovine CNS mastitis 
There is high pressure on farmers to increase individual cow productivity. As a result of this, 
farmers have become more reliant on antibiotics (McKenna, 2011). Antibiotics are used for 
treatment and prevention of bovine mastitis and metritis (Walther et al., 2008). They are also 
used for promoting growth in animals, as therapeutics and prophylactics in livestock 
production (Sawant et al., 2005). Some of the antibiotics used in farms include Penicillin, 
Oxacillin, Cefazoloin, Clindamycin, Tobramycin, Ciprofloxacin, Tetracycline, Erythromycin 
and beta lactams (Sawant et al., 2005; Gao et al., 2012). Recent studies show specific 
differences in resistance to antibiotics by different CNS at their species level (Luthje and 
Schwardz, 2006; Waller et al., 2011; Saini et al., 2012). In a study by Sawant et al. (2009), 
Staphylococcus epidermidis was resistant against Erythromycin, Methicillin and Pirlimycin 
but other CNS species including Staphylococcus simulans, Staphylococcus hyicus and 
Staphylococcus chromogenes were susceptible. Resistance against Ampicillin by 
Staphylococcus hyicus, Staphylococcus epidermidis and Staphylococcus chromogenes was 
also indicated by Sawant et al. (2009). According to Pitkala et al. (2004) the resistance 
pattern of some antibiotics for Staphylococcus aureus and CNS including Erythromycin, 
Streptomycin, Gentamycin and Oxacillin was between 0 -5.1% and 0-9.96% respectively. In 
that study, resistance to Penicillin was high for Staphylococcus aureus and CNS (52.1% and 
32% respectively).  
 
The prevalence of antimicrobial resistant CNS bacteria such as Staphylococcus epidermidis, 
Staphylococcus haemolyticus, Staphylococcus chromogenes and Staphylococcus simulans 
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against penicillin was 70%, 33%, 18% and 0%, respectively (Sampimon, 2009). Resistance 
against Oxacillin, Tetracycline, Sulfonamides, Trimethoprim, Clindamycin, Methicillin and 
Kanamycin by CNS has also been indicated (Gentilini et al., 2002; Moon et al., 2007; 
Bengtsson et al., 2009; Frey et al., 2013). Apart from dairy cows, bacteria in raw milk of 
other livestock animals have been reported to show resistance to antibiotics. Lollai et al. 
(2008) indicated resistance in isolates of milk samples gotten from sheep against some 
antibiotics by CNS. Resistance to penicillin in sheep is lower compared to cattle (Lollai et al., 
2008). Factors such as incidence of disease, cost of treatment, type of antibiotics, farm 
management practices and level of education influence the use of antibiotics for treatment of 
mastitis (Grave et al., 1999; Sawant et al., 2005). The continual use of antibiotics in livestock 
production has led to increase in resistance to several antibiotics by bacteria.  When a brand 
of antibiotic is used for a long period without prescriptions by a trained expert or veterinarian, 
resistant to antibiotics by bacteria may result (Carlet et al., 2012). Other causes of resistance 
to antibiotics by bacteria also include the indiscriminate use of antibiotics for treatment of 
cows and inappropriate dosage of the antibiotic drugs to animals (Alanis, 2005; Rusell and 
Houlihan, 2006). 
 
2.7. Virulence characteristics of CNS 
The role CNS play in the infection of cow mammary glands cannot be over emphasized. 
Though, antibiotics have been used to treat cows that show mastitis and persistent intra 
mammary infections caused by CNS species (Taponen et al., 2006; Simojoki et al., 2009); 
treatment has always been done as a group. There is difference in the virulence determinates 
of CNS.  In most cases CNS are often not identified at the species level but as a group. This is 
because the diagnostic relevance of CNS species in dairy management has not yet been 
critically looked into (Zadoks and Watts, 2009).  
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It is essential to identify mastitis pathogens at the species level including CNS (Rossito et al., 
2002; Pitkala et al., 2004). Mastitis causing pathogens possess different levels of 
pathogenicity and virulence characteristics (Zhang et al., 2000; Waller et al., 2011). 
According to Zhang and Maddox. (2000) the severity of infection caused by Staphylococcus 
chromogenes in cows is much higher than other CNS.  Staphylococcus chromogenes known 
as a minor mastitis pathogen can cause as much damage to cow mammary glands when 
compared to Staphylococcus aureus (Myllys et al., 1994). Information on species-specific 
differences in terms of their virulence characteristic will help in effective mastitis control 
programmes and management on dairy farms. 
 
2.8. Identifying CNS from milk samples 
Coagulase negative staphylococci are a group of Staphylococcus species that are often 
isolated from milk of cows with clinical mastitis, subclinical mastitis and even in normal 
milk. They are known to be pathogens that are becoming dominant in the cause of bovine 
mastitis. About 39 different species of CNS have been characterised. Identification of CNS in 
most cases is treated as a group and not as individual species. Recently it was reported that 
different species of CNS exhibit different virulence characteristics (Zhang and Maddox, 
2000; Waller et al., 2011).  Identifying CNS as a group may not be sufficient in effective 
therapy and mastitis control programmes.  
 
The standard for identifying CNS at the species level is the use of conventional biochemical 
tests. This includes growth of species in various prepared media, morphology of species in 
colonies, gram staining, catalase production and coagulase test among others. The use of 
conventional biochemical tests is demanding, expensive and time consuming (Couto et al., 
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2001). Several commercial biochemical kits have been developed to identify CNS at the 
species level phenotypically. Staph-zym system, ID 32 staph test and ATB 32 staph 
differentiation system are some commercial biochemical test kits that have been used to 
identify CNS at the species level (Deinhofer and Pernthaner, 1995; Thorberg and 
Brandstrom, 2000; Capurro et al., 2009). The use of ID 32 staph test for identifying CNS is 
efficient and also cheap when compared to staph-zym test (Thorberg and Brandstrom, 2000; 
Sampimon et al., 2009b). There is limitation in the use of commercial biochemical kits for 
identification of all species of CNS from animal source because the kits were originally 
designed to identify CNS in humans (Bes et al., 2000). The use of molecular method for 
identifying CNS species still remains the best to date (Zadoks and Watts, 2009). 
 
2.9. Risk management practices and spread of CNS species during milking 
Coagulase negative staphylococci pose a threat to the mammary gland in a poorly managed 
milking parlour and farm environment (Hundera et al., 2005). They are contagious and can 
persist in mammary glands and cow teat canal of infected cows thereby increasing the risk of 
infection to uninfected cows during milking (Peterrson-Wolfe et al., 2010). Good 
management practices and hygiene in the milking parlour are vital in preventing the spread of 
bacteria during milking (Yuen et al., 2012). The risk of infection for contagious and 
environmental mastitis pathogens including CNS increases when the milking machine is 
poorly managed (Philip et al., 2011).  Unethical practices in the milking parlour expose cows 
to mastitis causing organism (Yuen et al., 2012). Some practices such as using the same 
towel to clean cows’ udders and improper drying of cow teats during milking of cows will 
increase the spread of mastitis causing organisms (Jones, 2010).  
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2.9.1. Managing dairy cows against possible spread of bacteria in the milking parlour 
Proper cleaning of cow teats with disinfectants before milking, dipping of teats with 
chemicals, proper hygiene, culling of chronically infected cows and effective cow therapy are 
practices employed to reduce the load of mastitis causing organisms around cow udder during 
milking (Barkema et al., 2006). In a standard dairy farm according to Food standards agency 
Scotland (2007), proper washing of hands before and during the milking process, wearing of 
clean clothes by milking operators and the use of physically healthy milking personnel should 
be maintained when milking cows. This helps to cub the possible spread of mastitis causing 
organism from one cow to another and also prevent milk from bacterial contamination.  
 
According to Dufour et al. (2012) wearing of gloves by milking personnel during the milking 
process reduces intra mammary infection by Staphylococcus aureus. Regular cleaning and 
sanitation of milking equipment, proper cleaning of vacuum system, clean milking 
environment, right use of cleaners and sanitizer during milking prevents the contamination of 
raw milk with bacteria (NIANR, 2006).  Fore stripping of cows and regular screening of fore 
milk samples before attaching milking clusters to udders are also effective measures used to 
reduce the spread of bacteria during milking (Oliver, 2012). 
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CHAPTER 3 
Incidence and antimicrobial activity of Staphylococcus species in bovine milk from a 
dairy farm in Eastern Cape, South Africa 
Abstract 
The aim of the current study was to investigate the incidence of Staphylococcus species on a 
commercial dairy farm and their antimicrobial sensitivity. Several convention biochemical 
tests and the API
®
 staph kits (bioMerieux, France) were used to identify the bacterial 
organisms to their species level. The antimicrobial activity was determined according to the 
Clinical Laboratory Standard Institute (CLSI). A total of 217 milk samples collected over a 
period of nine months were cultured for bacteria analysis. Out of  the 217 milk samples that 
were examined, thirteen different Staphylococcus species were identified from 86 (39.63%) 
positive isolates, with Staphylococcus xylosus (22.09%), Staphylococcus hominis (15.11%) 
and Staphylococcus haemolyticus (11.63%) being the most frequently isolated. 
Staphylococcus xylosus (80%), Staphylococcus sciuri (60%), Staphylococcus aureus 
(53.33%), Staphylococcus haemolyticus (46.67%), Staphylococcus epidermidis (46.67%) and 
Staphylococcus chromogenes (40%) showed resistance against fifteen different antimicrobial 
agents that were used. These results indicate high rates of incidence and multiple drug 
resistance of Staphylococcus species against several antimicrobial drugs, including penicillin 
and ampicillin, which are intensively used on farms without any antibiotic susceptibility test 
and consequently call for drastic measures.   
Key words:  mastitis causing pathogens, Staphylococcus species, antibiotic susceptibility, 
multiple drug resistance.    
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3.1. Introduction 
Mastitis is the most expensive disease in dairy farms (Dufour et al., 2012). Increase in the 
rate of mastitis incidence in a herd affects the welfare of cows (Hogeveen et al., 2011).  Cows 
infected with mastitis experience reduced milk yield, which may lead to huge economic 
losses to the farmer (Halasa et al., 2009; Ampe et al., 2012). Several hundreds of bacteria 
have been linked with the cause of mastitis (Smith et al., 2001; Batavani et al., 2007). The 
most common bacteria that cause mastitis challenges in dairy farms are Staphylococcus 
species (Taponen et al., 2006; Sawant et al., 2009), which are comprised of both the 
coagulase positive staphylococci (CPS) e.g  Staphylococcus aureus and the coagulase 
negative staphylococci (CNS) e.g Staphylococcus epidermidis, Staphylococcus sciuri, 
Staphylococcus haemolyticus, Staphylococcus hyicus among others. Coagulase negative 
staphylococci comprises of a group of species which differ in their ability to cause mastitis 
infection (Zhang and Maddox, 2000; Waller et al., 2011). 
 
Lately, CNS has evolved to be more significant as bovine a mastitis causing organism 
(Simojoki et al., 2011). Isolates of CNS species are habitually identified in bovine milk of 
intramammary infection (Tenhagen et al., 2006). They cause both clinical and subclinical 
mastitis in cattle (Supre et al., 2011). Though, clinical mastitis by CNS species maybe placid 
in some cases (Taponen et al., 2009). Common CNS species isolated from bovine mastitis 
include Staphylococcus chromogenes, Staphylococcus xylosus, Staphylococcus epidermidis, 
Staphylococcus sciuri and Staphylococcus haemolyticus (Taponen et al., 2006; Kot et al., 
2012). Other CNS species e.g Staphylococcus saprophyticus, Staphylococcus hominis, 
Staphylococcus warneri, Staphylococcus capitis e.t.c from bovine mastitis have also been 
well documented (Sampimon et al., 2011).  
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 In several nations of the world CNS species have been indicated to be a preponderant agent 
causing mastitis infections in cows when compared to other mastitis causing agents (Pitkala 
et al., 2004; Piepers et al., 2007; Pyorala et al., 2009). However, prevalence of CNS varies 
from country to country (Taponen et al., 2009). Factors like farm area and or environment 
(Piessens et al., 2012), farm management system (Ayano et al., 2013) and season of the year 
may influence the incidence of the bacterial species in a farm.  
 
A survey carried out in South Africa for instance indicated that CNS were a major cause of 
both clinical and sub-clinical mastitis infection (Petzer et al., 2009). Various factors were 
linked to the CNS spread among cow herds in South Africa these included large herd size, 
meagre milking parlour, inefficient milking machine maintenance, influx of new stock of 
cows and high milk yield by cows were the reasons for CNS spread among cow herds in 
South Africa. Most studies have reported CNS as a group and not at their species level. 
Conversely, CNS species differ in their ability to cause infection in cows due to their 
different virulence (Simojoki et al., 2011). Distribution of CNS also varies within different 
regions of a particular country (Koivula et al., 2007; Shekhan et al., 2011). Influence of time 
of the year, parity and stage of lactation have also been indicated to determine the distribution 
of CNS pathogens from different regions within a country (Grohn et al., 2004; Koivula et al., 
2007; Taponen et al., 2007). Thus, the need to identify CNS to their species level is important 
for effective mastitis control programs (Supre et al., 2011). 
 
There is increased use of antimicrobials for the treatment of mastitis in many farms (Walther 
et al., 2008), during lactation and in the dry cow stage treatment (Sawant et al., 2005) Several 
Staphylococcus species are resistance to antimicrobials (Sampimon et al., 2011). According 
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to the World Health Organisation (WHO, 2000) the rate of increase of bacterial resistance to 
antibiotics is worrisome.  
 
Dairy farmers in the Eastern Cape Province of South Africa are aware of Staphylococcus 
aureus to be a cause of mastitis, but not the other species. Farmers acknowledged mastitis to 
be one of the biggest challenges that they face in their dairy farms. This study aimed to 
investigate the incidence of Staphylococcus species and the in-vitro antimicrobial sensitivity 
pattern of these species in milk of cows collected over a nine month period in 2012, from a 
dairy farm located in the Eastern Cape of South Africa. 
 
3.2. Material and methods 
3.2.1. Study site description 
The study was conducted in a dairy farm located in Middle drift of Nkonkobe municipality in 
the Eastern Cape Province of South Africa. The farm was on 250 hectares of land with six 
hundred milking cows, producing 3000-3500 litres of milk per day. The average annual 
rainfall of the farm is 591 mm per annum. Rainfall from May – September is less than 25 mm 
per annum and 50 -100 mm from November – March of every year. The topography of the 
farm land is flat with gentle slope and an altitude of 420 - 470 m. In July of every year the 
farm has a mean daily temperature of between 5.0
o
C and 28.2
o
C.  
 
3.2.2. Animal description 
Three dairy breeds viz Friesian, Jersey and their crosses (Friesian x Jersey) were kept for 
milk production. Milk samples were collected from each of the breeds for bacterial 
examination during the nine month period of study. Each cow that was used for milk 
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sampling was identified based on their colours, information from the farmers and ear-tags. 
Data including lactation stage and parity of the cows were taken at each sampling day. 
 
3.2.3. Milk sample collection 
Composite raw milk samples were collected from selected cows in a 10 ml sterile sampling 
bottle after pre-milking test (strip cup test and California mastitis test) were carried out on the 
cows. Milk sampling bottles were thereafter labelled appropriately and immediately kept in a 
cooler box with ice before they were transported to the laboratory for bacterial culture 
analysis. Milk samples were collected between March – November, 2012 which accounted 
for three different sampling periods (hot-wet, cold-dry and the hot-dry) of the year, 
respectively; and this was done twice for each sampling period.  
 
3.2.4. Isolation and identification of Staphylococcus species 
3.2.4.1. Culturing of milk samples in Mannitol salt agar 
Milk samples were aseptically streaked in a freshly prepared Mannitol salt agar within 24- 48 
hours of collection from the farm and incubated at 37
o
C for 24-48 hours. Isolates that gave a 
yellow colour with fermentation on Mannitol salt agar were sub-cultured in nutrient agar.  
  
3.2.4.2. Sub-culturing of milk samples in nutrient agar 
Presumed isolates that were positive in Mannitol salt agar were sub-cultured again in a 
freshly prepared nutrient agar (within 24 hours) and they were then placed in an incubator for 
24-48 hours. This is done so as to get a pure colony of the bacteria isolate. 
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3.2.4.3. Gram’s staining test 
All presumed cultures of Staphylococcus species were subjected to gram’s stain. Few 
colonies of pure cultured isolates were aseptically picked from the nutrient agar and then 
smeared on a sterile glass slide. The smeared culture was heat fixed to dryness. Crystal violet 
(0.5%) was added to the smear and left for 1 minute. Water was used to wash off the stain 
from the slide. Sufficient solution of iodine was again added to the smear and left for I 
minute. Water was used to wash off the stain. Ethanol (95%) was afterward used to rinse the 
stain from the slide. Safrani solution was finally added to the smear for 2 minutes before 
being washed with water. The smear was allowed to dry for a few minutes before they were 
viewed under a light microscope to determine the colony structure of the bacteria species. 
The smear of each bacteria species was viewed under the x10, x40 and x100 magnification. 
Gram’s stain smears that were positive gave a grape-like clustered shape with deep blue to    
purple colour.  
3.2.4.4. Oxidase test 
Few colonies of isolates from nutrient agar from presumed Staphylococcus species were 
picked aseptically using a sterile loop and then placed on an oxidase test strip paper. All 
isolates that turned purple on the test strip paper after 10 seconds were suspected to be 
Staphylococcus species. 
3.2.4.5. Catalase test 
Pure cultures of presumed Staphylococcus species from nutrient agar were aseptically 
transferred onto a clean glass slide. Few drops of 3% H2O2 were then added to the cultures. 
Positive cultures of Staphylococcus species gave out bubbles of oxygen within 5 seconds 
after adding H2O2. 
 
 54 
 
3.2.4.6. API Staph kit test for identification of Staphylococcus species 
All presumed isolates were finally confirmed to their species level using the API
®
 staph kit 
(bioMerieux, France). Homogeneous inoculums of pure cultured isolates were prepared with 
turbidity equivalent to 0.5 McFarland using the API
®
 Staph medium. Pipette was used to fill 
the micro tubes of the API kit with the inoculated API Staph medium. Mineral oil was added 
to the arginine dihydrolase (ADH) and urease (URE) tests to ensure anaerobiosis. The 
incubation box of the API kit was filled with 5mls of distilled water and closed tightly before 
incubating at 37
0
C for 24hrs. After incubation one drop of API Staph reagent was added to 
the inoculated micro tubes to determine their reactions. The reactions of the inocula were 
read using the apiweb 
TM
 identification software (Biomerieux., Inc Quebec).  
 
3.2.5. Minimum Inhibitory Concentration (MIC) determination 
Isolates that were identified to their species level were subjected to in-vitro drug sensitivity 
tests using the disc diffusion method as postulated by the Clinical Laboratory Standard 
Institution (CLSI, 2006). Briefly, few colonies of isolates were aseptically inoculated in 
normal saline to the desired turbidity (0.5 McFarland standards). With the aid of a sterile 
cotton swab, the inocula were evenly spread on Muller-Hinton agar in a petri dish. The 
antibiotic discs were then gently pressed on the agar and the petri dishes placed in an 
incubator for 24 hours at 37
o
 C. The MIC of each isolate was afterward determined by 
measuring (in millimetres) the zones of inhibition in the Mueller Hinton agar with a metre 
rule so as to obtain the diameter of inhibition of the different isolates. Among the antibiotics 
used were Levofloxacin, Ciprofloxacin, Kanamycin, Meropenem, Ofloxacin, Tetracycline, 
Gentamicin, Erythromycin, Imipenem, Chlorofenicol, Nalidixic acid, Amoxicillin, Penicillin, 
Ampicillin and Vancomycin. 
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3.2.6. Statistical analysis 
Data were analysed using both Microsoft Excel (2007) and SAS (2003). Descriptive statistics 
to generate percentage distribution was performed using Microsoft Excel (2007). Chi-square 
test (p< 0.05) was employed to assess the association between incidence of Staphylococcus 
species and risk factor variables (such as stage of lactation, parity number and period of the 
year of milk sample collection) using SAS (2003). 
 
3.3. Results 
From the total of 217 raw milk samples that were examined for bacterial growth, 13 different 
Staphylococcus species were isolated from 86 (39.63%) positive samples. The distribution of 
Staphylococcus species is presented in Table 3.1. The most frequently isolated 
Staphylococcus species were Staphylococcus xylosus (22.09%), Staphylococcus hominis 
(15.11%), Staphylococcus haemolyticus (11.63%), Staphylococcus sciuri (10.64%) and 
Staphylococcus warneri (9.3%). About 3.38% of the remaining species were due to 
Micrococcus spp. From the 86 positive isolates bacterial species that were identified, the 
proportion of Staphylococcus species across the different sampling periods was 10%, 38% 
and 38%, respectively with respect to the total milk sampled at the different sampling period 
(Table 3.2). Among the 13 different Staphylococcus species isolated from milk samples, 
Staphylococcus xylosus (10%, 10.52%, and 36.84%), Staphylococcus epidermidis (10%, 
2.63% and 5.26 %), Staphylococcus haemolyticus (40%, 5.26% and 10.65%) and 
Staphylococcus sciuri (10%, 7.89% and 13.15%) were identified at each of the different 
sampling periods (Table 3.2). There was significant difference (0.0039 and 0.0001) in the 
incidence of Staphylococcus species and some risk factors in the farm which include the 
period of milk sample collection and the stage of lactation at p < 0.05 (Table 3.3). 
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Table 3. 1 Proportion of Staphylococcus species isolated from 86 positive bovine milk 
samples.  
 
Staphylococcus species Number (%) 
S. epidermidis 4 (4.65) 
S. xylosus 19 (22.09) 
S. aureus 3 (3.48) 
S. haemolyticus 10 (11.63) 
S. hominis  13 (15.11) 
S. sciuri  9 (10.46) 
S. chromogenes  5 (5.81) 
S. warneri  8 (9.3) 
S. auricularis  4 (4.65) 
S. hyicus  1 (1.16) 
S. saprophyticus  2 (2.32) 
S. cohnii- cohnii  3 (3.48) 
S. cohnii- urealyticus  2 (2.32) 
Others  3 (3.48) 
Total 86 (100) 
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Table 3. 2. Distribution of Staphylococcus species isolates identified from milk samples 
at different sampling periods of the year. 
 
 N= 76 N=81 N=60 
Staphylococcus species Cold-dry (%) Hot-wet (%) Hot-dry (%) 
S. epidermidis 1(10) 1 (2.63) 2 (5.26) 
S. xylosus 1(10) 4 (10.52) 14 (36.84) 
S. aureus 2(20) - 1 (2.63) 
S. haemolyticus 4(40) 2 (5.26) 4 (10.52) 
S. hominis 1(10) 12(31.57) - 
S. sciuri 1(10) 3 (7.89) 5 (13.15) 
S. chromogenes - 3 (7.89) 2 (5.26) 
S. warneri - 6 (15.78) 2 (5.26) 
S. auricularis - 4 (10.52) - 
S. hyicus - 1 (2.63) - 
S. saprophyticus - - 2 (5.26) 
S. cohnii- cohnii - - 3 (6.97) 
S. cohnii- urealyticus - - 2 (5.26) 
Others - 2 (5.26) 1 (2.63) 
Total 10 (100) 38 (100) 38 (100) 
N: Total number of milk examined at each sampling period. 
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The antibiotic sensitivity test results for 78 isolates of CNS species against 15 different 
antibiotics are represented in Table 3.4.  On the whole, the antimicrobial resistance test of the 
Staphylococcus species showed the lowest resistance to Levofloxacin (1.3%), Imipenem 
(2.6%), Ofloxacin (2.7%), Gentamicin (5.1%), Ciprofloxacin (5.1%), Chlorofenicol (5.1%), 
Meropenem (6.8%), and Kanamycin (7.7%), whereas Staphylococcus species isolates showed 
the highest resistance to penicillin (83%), Nalidixic acid (79%) and Ampicillin (63%) 
respectively. Considering individual Staphylococcus species, Staphylococcus cohnii-
urealyticus was 100% resistant to Erythromycin, Nalidixic acid, Imipenem, Vancomycin, 
Penicillin and Ampicillin,  Staphylococcus saprophyticus to Vancomycin, Penicillin, 
Amoxicillin and Amoxicillin and Staphylococcus cohnii- cohnii to Nalidixic acid, Penicillin 
and Ampicillin. 
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Table 3.3 Chi-square test for potential risk factors associated with the incidence of 
Staphylococcus species. 
 
Risk factor   Group Number examined               X
2
-values 
1
Sig. 
Parity   First lactation 25 24.7182 ns 
   Second lactation 68 
   Third lactation 57 
   Fourth lactation 67 
Stage of lactation   Early (1-100) 28 51.9845 ** 
   Mid (101-200) 117 
   Late (201< ) 72 
Sampling time                Cold-dry 76 98.2789 *** 
(Season)   Hot-wet 81 
   Hot-dry 60  
1Chi Square values along the same column were significant at ** P˂0.01; ***P˂0.001 but not 
significant at ns P˃0.05 respectively. 
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Table 3.4 Distribution of resistant Staphylococcus species to different antibiotics.  
                                                                                                            Number of antimicrobial resistant isolates (%) 
Staphylococcus spp N CIP LEV OFX MEM E NAL IMI VA PG GM T K AM C AP 
S. haemolyticus 9 0 0 0 0 3(33) 7(78) 0 6(71) 6(71) 0 3(33) 0 2(33) 0 9(100) 
S. aureus 3 0 0 0 0 1(33) 2(67) 1(33) 2(67) 2(67) 2(67) 1(33) 0 0 0 3(100) 
S. sciuri 7 2(29) 0 0 0 4(57) 7(100) 0 4(57) 5(71) 1(14) 0 3(43) 0 3(43) 6(86) 
S. hominis 14 0 0 0 0 0 13(93) 0 2(14) 13(93) 0 4(29) 0 1(7) 0 NA 
S. epidermidis 3 0 1(33) 0 0 2(67) 1(33) 0 1(33) 3(100) 0 1(33) 0 2(67) 0 NA 
S. xylosus 20 2(10) 0 2(10) 5 14(70) 13(65) 0 16(80) 18(90) 1(5) 2(10) 3(15) 13(66) 0 18(90) 
S. auricularis 4 0 0 0 0 0 3(75) 0 0 3(75) 0 2(50) 0 1(25) 0 NA 
S. chromogenes 4 0 0 0 0 1(25) 3(75) 0 1(25) 3(75) 0 1(25) 0 1(25) 0 0 
S. warneri 6 0 0 0 0 1(17) 6(100) 0 1(17) 5(83) 0 0 0 0 0 6(100) 
S. hyicus 1 0 0 0 0 0 1(100) 0 0 0 0 1(100) 0 0 0 NA 
S. cohnii- cohnii 3 0 0 0 0 2(67) 3(100) 0 2(67) 3(100) 0 1(33) 0 0 0 3(100) 
S. cohnii-urealyticus 2 0 0 0 0 2(100) 2(100) 2(100) 2(100) 2(100) 0 0 0 NA 1(50) 2(100) 
S. saprophyticus 2 0 0 0 0 0 1(50) 0 2(100) 2(100) 0 0 0 2(100) 0 2(100) 
Total 78 4(5.1) 1(1.3) 2(2.7) 5(6.4) 30(39) 62(79) 2(2.6) 39(50) 65(83) 4(5.1) 16(21) 6(7.7) 22(28) 4(5.1) 49(63) 
NA: Not available. N: Number of isolates, CIP: Ciprofloxacin, LEV: Levofloxacin, OFX: Ofloxacin, MEM: Meropenem, E: Erythromycin, 
NAL: Nalidixic acid, IMI: Imipenem, VA: Vancomycin, PG: Penicillin-G, GM: Gentamycin, T: Tetracyline, K: Kanamycin, AM: Amoxicillin, 
C:Chlorofenicol,AP:Ampicillin. 
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Figure 3. 1 Distribution of multiple drug resistance to 15 antimicrobial drugs among 78 
isolates of Staphylococcus species from bovine milk.  
I-III= Ciprofloxacin, Levofloxacin and Ofloxacin, IV-VI= Meropenem, Erythromycin and 
Nalidixic, VII-IX= Imipenem, Vancomycin and Penicillin, X-XII= Gentamicin, Tetracycline 
and Kanamycin, XIII-XV= Amoxicillin, Chlorofenicol and Ampicillin. 
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3.4. Discussion 
From an aggregate of 217 milk samples that were collected throughout the three sampling 
period of the year, 86 (39.63%) were positive for Staphylococcus species. Thirteen different 
Staphylococcus species were identified among the 86 isolates that tested positive. 
Staphylococcus xylosus (22.09%), Staphylococcus hominis (15.11%), Staphylococcus 
haemolyticus (11.63%) and Staphylococcus sciuri (10.46%) were the most frequently isolated 
species in this study (Table 3.1). This result is somewhat in line with a study carried out in 
Canada (Davidson et al., 1992). Also, in the study by Kot et al. (2012) Staphylococcus 
xylosus was observed to be the most frequently isolated species. Farm management system 
and the farm surroundings may be a possible reason for such findings (Bendahou et al., 2008; 
Ayano et al., 2013). Piessens et al. (2012), in their study reported that farm environment may 
sometimes be a reservoir for Staphylococcus species. Some Staphylococcus species including 
Staphylococcus xylosus, Staphylococcus hominis and Staphylococcus haemolyticus are 
known to be opportunistic in nature and may find their way into the mammary gland of cows 
(Schukken et al., 2009). Conversely, these Staphylococcus species have been reported to 
cause intra mammary infections in cows (Quirk et al., 2012).  
 
On account of the period of the year that milk samples were collected, more Staphylococcus 
species (at the species level) were observed in the hot and dry period of the year when 
compared with the other periods of the year (Table 3.2). The reason for this may be due to the 
adaptive ability and persistent nature of some Staphylococcus species to the mammary glands 
of cows (Piessens et al., 2012). In the current study, a particular Staphylococcus species was 
assumed to persist when it was isolated at least once in each sampling day across the three 
different sampling periods of the year. Thus, Staphylococcus epidermidis, Staphylococcus 
xylosus, Staphylococcus haemolyticus and Staphylococcus sciuri were assumed to persist in 
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cow udders. In another study by Taponen et al. (2007), Staphylococcus epidermis and 
Staphylococcus haemolyticus were also reported to persist in the udder of cows but 
Staphylococcus xylosus was transient. Staphylococcus species (especially CNS) may differ in 
their degree of persistence (Taponen et al., 2007). Also, incidences of specific bacteria 
species vary among the different months of the year (Koivula et al., 2007).  
 
In all, Staphylococcus xylosus and Staphylococcus hominis (22.09% and 15.11%) were the 
most frequently isolated species that were observed in the current study (Table 3.1). They 
more often than not occur as harmless organisms in both the human body and some parts of 
the animal skin (Taponen et al., 2008). However, they have been isolated from milk of cows 
that are lactating (Kenar et al., 2012). The least isolated Staphylococcus species was 
Staphylococcus hyicus (1.16%). This result is different from the study carried out in Turkey, 
where Staphylococcus hyicus (33.33%) was the most frequently isolated Staphylococcus 
species (Kirkan et al., 2005). In another study carried out in Morocco, a similar result in line 
with the current study was however observed (Bendahou et al., 2008).The variation in the 
frequency of isolation of these species may be as a result of difference in the study areas 
(Koivula et al., 2007). Again, from the current finding Staphylococcus cohnii-cohnii was the 
ninth frequently isolated Staphylococcus species. This result was similar to the study carried 
out by Kirkan et al. (2005).   
 
Staphylococcus aureus is a major mastitis causing pathogen in dairy farms. It was observed 
in this study to be the eighth most frequently (3.48%) isolated Staphylococcus species. The 
distributions of other Staphylococcus species include Staphylococcus warneri (9.3%), 
Staphylococcus auricularis (4.65%), Staphylococcus saprophyticus (2.32%) and 
Staphylococcus cohnii-urealyticus (2.32%) respectively. Few Staphylococcus species that 
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were identified including Staphylococcus warneri and Staphylococcus saprophyticus may 
have been as result of contamination from the milking clusters that were used in the farm. 
These species were also isolated from the milking clusters and not from farmers’ hands and 
may have been transferred from one cow to another from milk droplets in the milking 
clusters.  
 
Not much work has been done on the incidence of CNS (at the   species levels) as regards the 
time of the year milk samples are collected (Gillespie et al., 2009). However, some studies 
have indicated that the time of the year when milk samples are collected from cows for 
bacterial culture analysis influences the prevalence of mastitis causing pathogens in milk 
(Osteras et al., 2006; Gillespie et al., 2009). According to Koivula et al. (2007), 
Staphylococcus aureus were prevalent during the cold and dry period of the year than any 
other period of the year. The reasons given for their findings were linked with cow’s calving 
periods and farm management style. Shpigel et al. (2000) reported that there was increase in 
the incidence of mastitis caused by coliform bacteria in the wet and cold period of the year, 
but lower incidence of coliform bacteria was observed in the hot and dry period. In another 
study in Norway, Staphylococcus aureus and Streptococcus uberis were prevalent in the hot 
and dry period of the year but, Streptococcus dysgalactiae and CNS (reported as a group) 
were more prevalent in the cold and dry period (Osteras et al., 2006). This may give a 
rational insight for a probable link in the time of milk sampling and the incidence of 
Staphylococcus species in farms (Gillespie et al., 2009). 
 
More Staphylococcus species (at the species level) were isolated during the hot and dry 
period of the year in the current study. The number of species-specific isolates identified 
were 11, 10 and 6 for the hot-dry, hot-wet and cold-dry period of the year respectively (Table 
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3.2). The difference in the result may be due to the variation in the climatic conditions of the 
different sampling periods of the year (Piessens et al., 2012; Sampimon et al., 2011). The 
prevalence of mastitis causing pathogens in a farm is linked with multiple complex factors 
including environment, cow herd, clinical state of the udder of cow, and the farm itself 
(Thorberg et al., 2009; Supre et al., 2011; Ayano et al., 2013).   
 
Some Staphylococcus species cause damage to the mammary cow udder than others 
depending on their virulent attribute (Zhang et al., 2000; Thorberg et al., 2009). Their roles in 
causing damage to mammary tissues of cows (mostly CNS) and to initiate mastitis infection 
have not been plainly defined (Kirkan et al., 2005). However, relationships have been 
reported to exist between stage of lactation and the incidence of Staphylococcus species 
(Taponen et al., 2007; Abera et al., 2010). Heifers and primiparous cows are known to be 
infected with mastitis by Staphylococcus species more often when compared with 
multiparous cows, though the reason for this is not yet clear (Taponen et al., 2007). There 
was no significant difference (p= 0.9845) in the incidence of Staphylococcus species and the 
number of lactations per cow (Table 3.3). A significant association was however observed for 
the incidence of Staphylococcus species in relation to the stage of lactation (p= 0.0039) and 
the period of year of milk sampling (p= 0.0001). Abera et al. (2010) also reported no 
significant difference in the incidence of Staphylococcus aureus and the number of lactation 
in cows but, reported a significant association between the stage of lactation and the 
prevalence of Staphylococcus aureus in bovine milk. Lack of cleanliness of cow udder during 
dry periods was suggested by Abera et al. (2010) to influence the increase of bacteria on the 
skin of cow teat leading to possible high infection of bacteria in the udder.  
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Today, many farms are becoming dependant on antibiotics (Mc Kenna, 2011). The use of 
antimicrobials in dairy farms plays a significant role in the control of mastitis. Information 
about the variation that exists among specific Staphylococcus species is essential for mastitis 
therapy and management (Sawant et al., 2009). A large proportion of Staphylococcus species 
from this study were resistant to Erythromycin, Nalidixic acid, Vancomycin, Penicillin, 
Tetracycline, Amoxicillin and Ampicillin (Table 3.4). There is an increasing evolutionary 
trend of antibiotic resistance in infectious diseases in recent times (McKinzey, 2007). This 
may be the reason for the observed result in the current study. Hundred percent resistance 
was observed of several Staphylococcus species isolates to Ampicillin in the current study 
(Table 3.4). This was contrary to the report by Sawant et al. (2009) were most of the 
Staphylococcus species were susceptible to Ampicillin. 
 
In the study by Kot et al. (2012) high resistance to Penicillin was observed for 
Staphylococcus species. Penicillin and Ampicillin were the mostly used antimicrobials in the 
farm where this study was conducted. However, from our results Penicillin and Ampicillin 
may not be a proper choice for the treatment of Staphylococcus species (Kot et al., 2012) due 
to the high to these antimicrobials. The highest percentage of Staphylococcus species isolates 
that was resistant to Penicillin was among Staphylococcus xylosus, Staphylococcus hominis, 
Staphylococcus warneri, Staphylococcus sciuri and Staphylococcus haemolyticus (Table 3.4). 
All the isolates of Staphylococcus epidermidis gave 100% resistance to Penicillin (Table 3.4). 
This result is in accordance with the result of Sampimon et al. (2011) and Kot et al. (2012) 
whose study showed that Penicillin resistance in Staphylococcus epidermidis was very high. 
 
Considering the results for specific species, 100% resistance was observed mostly for 
Staphylococcus cohnii-urealyticus and Staphylococcus saprophyticus. Resistance (100%) to 
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six out of fifteen antimicrobial agents was observed for Staphylococcus cohnii- urealyticus 
while Staphylococcus saprophyticus gave resistance (100%) to four out of fifteen 
antimicrobial agents that were used. The next Staphylococcus species with a high resistance 
(9 out of 15) to multiple antimicrobial agents was Staphylococcus sciuri from the current 
study (Table 3.4).  
 
Staphylococcus aureus gave resistance to 8 (Erythromycin, Nalidixic acid, Imipenem, 
Vancomycin, Penicillin, Gentamicin, Tetracycline and Ampicillin) out of the 15 
antimicrobial (Table 3.4). In Sweden, Persson et al. (2011) also observed resistance to 
Penicillin by Staphylococcus aureus in their study but not for Gentamicin and Erythromycin 
as observed in the current study. Staphylococcus aureus was susceptible to Chlorofenicol and 
Ciprofloxacin in our study and this is in line with the study carried out by Persson et al. 
(2011). All the Staphylococcus aureus isolates identified from this study were susceptible to 
Kanamycin. This is contrary to the report by Persson et al. (2011). The variation observed in 
the trend of Staphylococcus species against antimicrobial agents from this study may be as a 
result of difference in virulence strains of the different species that were identified (Zhang et 
al., 2000). The most susceptible Staphylococcus species (11 out of 15) to multiple 
antimicrobial agents was observed for Staphylococcus hyicus.  
 
As regards the number of isolates of Staphylococcus species that were resistant to multiple 
antimicrobial agents, 13 isolates of species were resistant to Imipenem, Vancomycin and 
Penicillin, while 10 isolates were resistant to Meropenem, Erythromycin and Nalidixic acid 
(Figure 3.1). Conversely, 4 isolates of Staphylococcus species were resistant to Gentamicin, 
Tetracycline and Kanamycin. This result is contrary to a study that was conducted in 
Argentina were all Staphylococcus species that were tested were susceptible to Gentamicin 
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(Gentilini et al., 2002). The least number of isolates (1) against multiple antimicrobial agents 
was observed for Ciprofloxacin, Levofloxacin and Ofloxacin (Figure 3.1). The result of huge 
multi-drug resistance witnessed on the farm may be due to the development of resistance by 
the Staphylococcus species prevalent in the farm of study to antimicrobial agents used for 
mastitis therapy. Frequent use of the same antimicrobial agents on a farm may lead to transfer 
of resistant gene among mastitis disease causing organisms (Gentillin et al., 2002).   
 
3.5. Conclusions 
There was relatively high incidence of Staphylococcus species with Staphylococcus xylosus, 
Staphylococcus hominis and Staphylococcus haemolyticus frequently identified in milk 
samples from the farm where this study was conducted. Stage of lactation and the period of 
the year of sample collection influenced the incidence of Staphylococcus species in the farm. 
High rate of multiple drug resistance against antimicrobials agents was also observed on the 
farm with Staphylococcus xylosus and Staphylococcus sciuri having the highest resistance 
rate against antimicrobial agents. The high resistance observed for most Staphylococcus 
species to multiple antimicrobial agents including Penicillin and Ampicillin which are 
frequently used on the farm suggests that these drugs may not be effective against most of the 
Staphylococcus species for mastitis therapy control and hereby calls for alternative 
antimicrobial agents to be used for treatment of mastitis disease in cows from the farm. 
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CHAPTER 4 
In-vitro antibacterial activity of Usnea barbata lichen extracted with methanol and 
ethyl- acetate against selected Staphylococcus species from bovine milk 
Abstract 
This study aimed at evaluating the antimicrobial potential of Usnea barbata lichen as a 
medicinal plant against selected Staphylococcus species isolated from raw milk of mastitis 
cows.  In-vitro screening of the methanolic and ethyl-acetate extracts of U. barbata were 
evaluated to determine their antimicrobial activity against thirteen different Staphylococcus 
species. The selected organisms were isolated from raw bovine milk by several biochemical 
tests and identified with an API
®
 staph kit (bioMerieux, France). The antimicrobial activity of 
the extracts were evaluated using both the agar well diffusion method and the broth micro-
dilution technique to determine the mean zone of inhibition and the minimum inhibitory 
concentration (MIC), respectively. Both the methanolic and ethyl-acetate extracts showed 
variable antimicrobial activity against the Staphylococcus species with mean zones of 
inhibition ranging from 0 - 34 mm in diameter.  Susceptibility by the Staphylococcus species 
tested in the methanol and the ethyl-acetate extract was 92.31% and 53.85%, respectively. 
The MIC result for the methanol extract ranged from 0.0390 to10 mg/ml, while that of the 
ethyl-acetate extract ranged from 0.15625 to 5 mg/ml. Results from this study revealed the in 
vitro microbial activity of U. barbata extracts which indicate its potential as a medicinal plant 
to be used in traditional medicine.             
Key words: Antimicrobial resistance, mastitis, microbial activity, medicinal plant.  
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4.1. Introduction  
Mastitis, an inflammation of the mammary gland especially in dairy animals is known to be a 
huge threat due to the resistance of several causative organisms to antimicrobial agents, 
leading to considerable economic losses in farms (Halasa et al., 2009). Mastitis in cows could 
be clinical or subclinical in nature. Clinical mastitis can be visibly seen from the appearance 
of raw milk of cows but in subclinical mastitis there is no apparent change in milk 
(Gianneechini et al., 2002).  Staphylococcus species are among the several pathogenic 
organisms that cause mastitis and are known to be resistant to a wide range of antimicrobial 
agents in several parts of the world (Pyorala and Taponen, 2009; Sampimon et al., 2011). In 
South Africa for example, a study conducted by Petzer et al. (2009) indicated that 
Staphylococcus species including Staphylococcus aureus and coagulase negative 
staphylococci (CNS) are the most prevalent pathogens (with increasing trend on a yearly 
bases) that cause mastitis in dairy cows and they have also become important mastitis causing 
pathogens. 
There are different Staphylococcus species that may be involved in the cause of mastitis in a 
dairy farm. There is however sparse or no information on the sensitivity of these bacteria 
species (isolated from bovine milk) to extracts of U. barbata. 
Several bacterial resistant organisms are reported to surpass the effect of newly developed 
antibiotic drugs (Gould, 2009). The rise in the trend of resistance by mastitis causing 
organisms to antibiotics is posing a serious challenge to the society (Tiwari et al., 2013).  
However, some plants have been discovered to possess active antimicrobial ingredients 
which can be effective to treat various ailments both in humans and animals (Alviano and 
Alviano, 2009). Antimicrobials are widely used for treatment of various ailments both in 
humans and animals. Over the years, the continuous use of antimicrobials in the dairy sector 
has led to the emergence of resistant strains of several pathogens that are linked to the cause 
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of mastitis disease in animals (Pitkala et al., 2004). Mastitis disease causing organisms 
develop resistance to antimicrobials through a systematic process which make them to 
withstand the effect of drugs used against them (Suleiman et al., 2010). Even though several 
efforts have been made to combat the emergence of these organisms, by way of introducing 
new antimicrobial agents there is yet no lasting solution to the problem at present (Gould, 
2009). According to the World Health Organization (WHO, 2011), the global challenge of 
antimicrobial resistant to drugs is bothersome. Thus, the search for other effective drugs to 
address the situation is worthwhile (Dhanalakshmi et al., 2013). 
 
Many small-scale farmers have resorted to the use of herbal plants as alternatives instead of 
the conventionally known antimicrobial drugs to treat their animals (Masika et al., 2000). 
This practice has increased greatly in Africa. According to Ndip et al. (2007), Africa has the 
highest record of herbal plants usage as options for treating various diseases both in humans 
and in animals. Over 80% of Africans use plants as an alternative to treat different kinds of 
diseases (Madamombe and Afolayan, 2003). Several studies in different countries of the 
world have evaluated the use of U. barbata plant as a remedy to treat diseases in animals and 
humans because they possess some potential natural antimicrobial agents (Kirmizigul et al., 
2003; Rankovic et al., 2012). Usnea barbata lichens are epiphytes that grow on leaves of 
other trees and plants in a symbiotic relationship. Like other lichens they can also grow on 
rocks and soils with very low nutrient content (Vrablikova et al., 2006).  The use of U. 
barbata for the treatment of mastitis by rural dwellers in the Eastern Cape of South Africa 
was reported by Madamombe and Afolayan (2003).  
 
Presently, we are unaware of any study that has evaluated the antimicrobial activity of U. 
barbata plant on Staphylococcus species isolated from raw milk of cows with mastitis. The 
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current study aimed to evaluate the in-vitro antimicrobial activity of methanolic and ethyl-
acetate extracts of U. barbata lichens on some selected Staphylococcus species isolated from 
milk of cows. Virtually all the Staphylococcus species tested in our study have been 
implicated as potential bacterial organisms involved in mastitis disease of livestock animals 
(Taponen et al., 2006; Sampimon et al., 2011; Kot et al., 2012). In addition, the increasing 
trend in the prevalence of these bacterial organisms in our environment causing mastitis 
disease in cows as earlier indicated by Petzer et al. (2009) necessitated the study.  
 
4.2. Materials and Methods 
4.2.1. Study site 
The study site, milk collection, isolation and identification of Staphylococcus species are 
described in Chapter 3.  
 
4.2.2. Plant sample and extracts preparation 
Usnea barbata was harvested from the Hogback forest (32
oC 35′S 26oC 57′E) about 30 Km 
from Alice town, Eastern Cape, South Africa. The U. barbata lichen was selected based on 
the information of their use for the treatment of cattle with mastitis by farmers in that area. 
Identification of the plant was done at the University of Fort Hare where voucher specimens 
(Idah 2000/2) have been deposited. The U. barbata lichen was air-dried at room temperature 
(20- 25
o
C) for 10 days and thereafter ground into powder before it was serially extracted with 
methanol and ethyl acetate solvent, respectively. Extraction was done using a portion of 400g 
of the U. barbata plant lichen in an extraction bottle before adding the solvents (methanol 
and ethyl-acetate) and then shaken for 24 hours in a shaker (Edison, N.J., USA). After 24 
hours, the mixture was centrifuged at 1500 rpm for 10 minutes and filtered using a Whatman 
 80 
 
No. 1 filter paper. Filtrate was concentrated to dryness under reduced pressure at 40
o
 C in a 
rotary evaporator (Strike 202, Steroglass Italy). Extracts were stored in a tight lid container 
for further use.  
 
4.2.3. Test for antimicrobial sensitivity 
The agar well diffusion technique was used to test for the antimicrobial sensitivity of 
Staphylococcus bacteria to plant extracts. Break point with an inhibition zone of diameter of 
≥ 11 was chosen for bacterial susceptibility for the plant extracts and the antibiotic (Nyenje 
and Ndip, 2011). Few colonies of bacteria isolates from freshly prepared (within 24 hours) 
nutrient agar were added to sterile normal saline in a test tube with turbidity adjusted to 1 x 
10
8
 CFU/ml (McFarland standards) to make the required inocula for the experiment (Ndip et 
al., 2007). A sterile cotton swab was thereafter used to inoculate the standardized bacterial 
suspension in a radial pattern on Mueller Hinton agar plates (Oxoid, Basingstoke, England). 
The plates were after wards left to dry for about 5-10 minutes. Holes of about 6 mm in 
diameter were then aseptically punched to make wells (5 holes per plate) in the Mueller 
Hinton agar with the aid of a sterile cork borer. Each well was thereafter filled with 50 µl of 
extract at different concentrations (5, 10 and 20 mg/ml). The extracts (methanol and ethyl 
acetate) were dissolved in 5% dimethyl sulphoxide (DMSO) before adding them into the 
wells. Each plate was made in triplicate and left for 30 minutes for sufficient diffusion of the 
extracts into the agar before they were incubated at 37
o
C for 24 hours. The zones of 
inhibition were measured to the nearest millimetre after 24 hours. The mean zone of 
inhibition was calculated for each solvent; 0.01mg/ml of amoxicillin was used as positive 
control while Dimethyl sulphoxide (5%) was used as negative control.   
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4.2.4. Determination of minimum inhibitory concentration (MIC) of plant extracts 
 Minimum inhibitory concentration (MIC) of the plant extracts against the bacterial species 
was determined using the broth micro-dilution method in 96-well micro-titer plates. Series of 
dilutions were made for the extracts and for the standard antibiotic (amoxicillin) with 
concentrations ranging from 0.004875 to 10 mg/ml in 5% DMSO. The DMSO solution was 
dissolved in sterile distilled water to the desired concentration. Two-fold serial dilution of 
Mueller Hinton broth from stock solution (10 mg/ml) was prepared in the micro-titer wells 
and a standardized bacterial suspension (20µl) added into the wells except for the control 
wells, which contained broth and sterile distilled water, respectively. Plates were then 
incubated for 24 hours at 37
o
C. A drop of rezasurin solution as an indicator was added to the 
micro titer wells to indicate the growth. Bacterial growth was indicated by a colour change 
from purple to pink. The least concentration in the wells of the test solution that led to 
inhibition of growth was taken as the MIC.  
 
4.2.5. Statistical analysis 
The SPSS version 17.0 (Illnois USA, 2009) was used for statistical analysis. One way 
ANOVA test was used to evaluate if there was any significant difference in the diameter of 
zones of inhibition of the plant extracts and the standard antibiotic (amoxicillin). Statistical 
significance was considered at p < 0.05.   
 
4.3. Results 
The zones of inhibition for methanol extract ranged from 10 to 34 mm while that of ethyl- 
acetate ranged from 0 to 23 mm (Table 4.1). Amoxicillin (0.01 µg/ml) which was used as a 
positive control gave a zone of inhibition in the range of 17 to 47 mm (Table 4.1). The 
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DMSO (5%) used as negative control showed no activity. With reference to the break point 
(inhibition zone diameter ≥ 11), six out of the thirteen bacterial strains were the most resistant 
organisms to methanol and ethyl-acetate extract viz, Staphylococcus haemolyticus, 
Staphylococcus capitis, Staphylococcus cohnii-urealyticus, Staphylococcus cohnii-cohnii, 
Staphylococcus hominis and Staphylococcus saprophyticus. On the other hand, four strains: 
Staphylococcus xylosus, Staphylococcus sciuri, Staphylococcus lentus and Staphylococcus 
epidermidis, were the most susceptible organisms. There was statistical significance in the 
mean zone of inhibition of the standard antibiotic (amoxicillin) and the plant extracts 
(methanol and ethyl-acetate) at p < 0.05 (Table 4.1).  
Out of the thirteen Staphylococcus species that were tested, the susceptibility of the bacterial 
organisms to the standard antibiotic (amoxicillin) and methanol extract was 100% and 
92.31%, respectively while that of the ethyl-acetate extract was 53.85% (Figure 4.1). The 
MIC results showed that methanol and ethyl-acetate had an antimicrobial activity ranging 
from 0.0390 to 10mg/ml and 0.15625 to 5mg/ml, respectively while the MIC for amoxicillin 
on the other hand had a ranged of 0.625 to10 µg/ml (Table 4.2). 
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Table 4.1 Zone of inhibition (mm) of U. barbata extracts and amoxicillin against the test 
organisms.  
                                Solvent extracts of Usnea barbata plant (mg/ml) 
                            Methanol                              Ethyl-acetate                                 Amoxicillin 
 Species                5             10            20           5              10               20              0.01 
S. aureus 14 ±1 NA NA 0 ± 0 0 ± 0 15 ± 0.58 23 ± 1.5 
S. sciuri 15 ±1 17 ± 2 NA 13 14 ± 1.8 15 ± 3 30 ± 0.57 
S. xylosus 34 ± 1.7 NA NA 23 ± 1.2 NA NA 47 ± 1.5 
S. chromogenes 17 ± 1 18 ± 0.57 NA 13 ± 0.7 15 ± 1.7 NA 21 ± 3.1 
S. lentus 14 ± 1.7 17 ± 1 19 13 ± 0.57 14 ± 1.7 NA 17 ± 0.57  
S. cohnii 
a
 10 ± 1.5 NA NA 12  14 ± 0.9 19 ± 1.5 39 ± 1.5 
S. haemolyticus 16 ± 0.6 NA NA 8 ± 7.5  9 ± 6.3 14 ± 1.7 27 ± 1.5 
S. capitis 16 ± 14 NA NA 0  9 ± 6 10 ± 8 30 ± 6.5 
S. epidermidis 26 ± 1.5 NA NA 16 ± 2 19 ± 1.6  21 ± 0.6 37 ± 2.1 
S. warneri 22 ± 3 NA NA 14 ± 0.5 15 ± 0.4 16 ± 2 40 ± 0.6 
S. cohnii 
b
 18 ± 1.7 NA NA 0 ± 0  7 ± 5 9 ± 7 36 ± 1.1  
S. hominis 22 ± 1.7 NA NA 0 ± 0 14 ± 1.4 17 ± 2.5 39 ± 1 
S. saprophyticus 14 ± 1 NA NA 0 ± 0 10 ± 6  12 ± 10 20 ± 2 
(S. cohnii 
a
: Staphylococcus cohnii – cohnii, S. cohnii b: Staphylococcus cohnii – urealyticus). 
(NA: Not Available). (* values are in mean, ± standard deviation, n= 3).   
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Figure 4.1 Sensitivity of test organisms to amoxicillin, methanol and ethyl-acetate 
extracts at 5mg/ml. 
 
0
10
20
30
40
50
60
70
80
90
100
methanol
ethyl-acetate
amoxicillin
%
 o
f 
st
ra
in
 s
u
sc
e
p
ti
b
le
 a
t 
am
o
xi
ci
lli
n
 b
re
ak
 p
o
in
t 
o
f 
≥1
1
  m
m
 b
re
ak
 p
o
in
t 
Screened Usnea barbata extracts and amoxicillin  
susceptible
resistant
 85 
 
Table 4.2 Antibacterial activity of Usnea barbata extracts and amoxicillin against the 
test organisms.  
                                                                        MIC
a
 (mg/ml) 
Staphylococcus species Methanol Ethyl-acetate Amoxicillin 
S. aureus 1.25 2.5 6.25x10
-4
 
S. sciuri 3.125x10
-1
 1.5625x10
-1
 3.125x10
-4
 
S. xylosus na
b
 na   7.8125x10
-5
 
S. chromogene 10
c
 1.25 6.25x10
-4
 
S. lentus 10 6.25x10
-1
 5x10
-3
 
S. cohnii- cohnii  3.125x10
-1
 3.125x10
-1
 2.5x10
-3
 
S. haemolyticus 6.25x10
-1
 6.25x10
-1
 1.25x10
-3
 
S. capitis 6.25x10
-1
 1.5625x10
-1
 1.562
-4
 
S. epidermidis 1.5625x10
-1
 3.125x10
-1
 1.562
-4
 
S. warneri 3.90x10
-2
 3.125x10
-1
 2.5x10
-3
 
S. cohnii-urealyticus 3.125x10
-1
 3.125x10
-1
 6.25x10
-4
 
S. hominis 6.25x10
-1
 2.5 1.0x10
-2
 
S. saprophyticus 10 5 5x10
-3
 
a
 minimum inhibitory concentration,  
b 
Not active,  
c
 highest concentration of extract tested. 
 
 86 
 
4.4. Discussion  
The screening of the antimicrobial properties of U. barbata extracts in the current study 
indicated a significant activity with a range between 0 to 34 mm against all the 
Staphylococcus species that were tested. Most papers have reported the antimicrobial activity 
of U. barbata on bacteria and fungi isolated from human isolates (Weckesser et al., 2006; 
Kala and Senthilkuma, 2010; Wendakoon et al., 2012) but, information regarding the use of 
U. barbata extracts on bacteria isolates from animal origin (raw milk) is sparse. In the current 
study, the range of mean zone of inhibition for all organisms tested was between 0 to 34 mm. 
The least mean zone of inhibition was observed for Staphylococcus cohnii- urealyticus, 
Staphylococcus haemolyticus and Staphylococcus capitis while the highest zone of inhibition 
was observed for Staphylococcus xylosus, Staphylococcus sciuri, Staphylococcus lentus and 
Staphylococcus epidermidis.   In another study by Wendakoon et al. (2012), it was observed 
that the mean zone of inhibition for Staphylococcus aureus and Staphylococcus epidermidis 
isolates (from human origin) was between 11 to 32 mm; with chemical compounds including 
flavonoids, tannins, lignins and phenolic acid extracted from the lichen mentioned to be 
responsible for inhibiting the growth of the bacteria. These chemical compounds are known 
to initiate antimicrobial activities in many plants because they produce biological effect on 
micro-organisms. 
 
Iwalewa et al. (2007) reported that, saponins from plant extracts produce inhibitory effect on 
inflammatory disease of humans and animals. Rankovic et al. (2012) in their study identified 
usnic acid, norstictic acid, atranorin and chloroatranorin from acetone extract (of U. barbata 
lichen) as the active compounds that may be responsible for antimicrobial activity to bacteria. 
The differences in the inhibitory activity to the different Staphylococcus species in the current 
study may be due to the structural make up of the bacterial cells. The thickness of bacterial 
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cell membranes plays a role in the effectiveness (antimicrobial and bactericidal) of antibiotics 
when they are tested against bacteria in-vitro (Fennell et al., 2004; Okeleye et al., 2013). 
However, the inhibitory activities of the U. barbata lichen against the tested organisms in the 
current study indicate that they could be effective for treatment of cattle with mastitis disease 
caused by the selected Staphylococcus species.  
 
There is a dearth of information in literatures on the bacterial effect of ethyl-acetate extracts 
from U. barbata lichens. Though, ethyl-acetate has been used as an extraction solvent for 
other plants including Peltophorum africanum and Combretum molle (Okeleye et al., 2010; 
Nyenje and Ndip, 2011), but not with U. barbata lichen.  Extracts of U. barbata lichen from 
other solvents (such as acetone, methanol, carbon dioxide, water) have also been reported to 
be active against several bacteria organisms including Staphylococcus aureus, 
Staphylococcus epidermidis, Enterococcus faecalis, Bacillus subtilis, Escherichia coli and 
Micrococcus viradans (Madamombe and Afolayan, 2003; Cansaran et al., 2006; Weckesser 
et al., 2006; Rankovic et al., 2012; Wendakoon et al., 2012). In the current study, a good 
proportion of the bacterial species were susceptible to both the methanol and the ethyl-acetate 
extracts. All the bacterial organisms that were screened in the standard antibiotic 
(amoxicillin) were susceptible while the susceptibility of the tested bacterial organisms in 
methanol and ethyl-acetate extracts gave 92.31% and 53.85% respectively. This may be due 
to methanol solvent extracting more microbial inhibiting active compounds from the plant 
lichen because of its high polarity. In the study conducted by Parekh et al. (2005), methanol 
extract from 12 different plants gave a better antimicrobial activity than water (a lesser polar 
solvent) when screened against 5 different bacteria strain including Staphylococcus 
epidermidis.  According to Abu-Shanab et al. (2006) and Nyenje and Ndip (2011), organic 
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solvents effectively extract antimicrobial substances from medicinal plants as compared to 
other solvents.   
Several other studies on the activity of U. barbata lichen against bacterial organisms have 
also been reported. The MIC value observed by Rankovic et al. (2012) in their study ranged 
between 0.125 and 12.5 mg/ml for ten different bacterial organisms including Staphylococcus 
aureus, Bacillus subtilis, Escherichia coli and Bacillus subtilis in acetone extract which is 
close to the result in the current study. Madamombe and Afolayan (2003) and Cansaran et al. 
(2006), also reported a significant antimicrobial activity with MIC value as low as 0.1mg/ml 
for Staphylococcus aureus in methanol and acetone extract. However, the MIC value for the 
methanol extract against Staphylococcus warneri in the current study was as low as 0.039 
mg/ml though the overall activity of both extracts for all the tested organisms varies between 
0.039 - 10 mg/ml. This result suggests that U. barbata lichen extracted with methanol and 
ethyl-acetate solvents possess some potential antimicrobial compound that inhibited the 
tested organisms and may be broad spectrum.  Conversely, the variation in activity of the 
selected bacterial organisms screened in the U. babarta lichen (extract) may not be clearly 
understood in the current study. Further investigation on the activity of this plant against the 
tested microbial organisms (using other solvents) may be required in the present search for 
new antimicrobial drugs. 
4.5. Conclusion 
The methanol and ethyl-acetate extracts of U. barbata exhibited in-vitro antimicrobial 
activities with the methanol extracts being more active. The results of the antimicrobial 
activity of U. barbata in the current study also suggest the rationale behind the traditional use 
of U. barbata lichen for the treatment of mastitis in cattle by local farmers in the Eastern 
Cape Province of South Africa. It is therefore proposed that further investigation should be 
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carried out on the plant lichen to determine the natural bioactive compounds present in the 
plant.   
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CHAPTER 5 
In vitro study on the antibiogram pattern of Staphylococcus aureus and CNS species 
isolated from bovine milk in a commercial dairy farm 
Abstract 
The study aimed to screen milk samples for the presence of Staphylococcus aureus and 
Coagulase Negative Staphylococci (CNS) and also to evaluate the antimicrobial sensitivity 
pattern of Staphylococcus species to some selected antibiotics commonly used for the control 
of mastitis. An aggregate of 250 milk samples were collected from lactating cows in a 
commercial dairy farm over a period of nine months (March – November, 2012). 
Identification of bacterial isolates was done using several biochemical techniques and the 
API
®
 staph kit (bioMerieux, France) was used for confirmation of the isolates to their species 
level. The antimicrobial susceptibility pattern of individual Staphylococcus species was 
determined according to the Clinical Laboratory Standard Institute (CLSI). A total of 62 
(24.8%) species isolates were identified. On the whole, 11 different bacterial species were 
identified including S. xylosus (n= 20), S. saprophyticus (n= 10), S. aureus (n= 8), S. hominis 
(n= 6), S. warneri (n=4), S. sciuri (n= 4), S. chromogenes (n= 3), S. lentus (n= 3), S. 
haemolyticus (n= 2), S. capitis (n= 1) and S. cohnii-cohnii (n= 1). The most commonly 
isolated bacteria were S. xylosus (n= 32.25%), S. saprophyticus (n= 16.12%) and S. aureus 
(12.90%). Most isolates that were identified were resistant to Penicillin (67.7%), Nalidixic 
acid (66.1%) and Vancomycin (40.5%). The results from the current study indicate that 
Staphylococcus species are resistance to beta-lactam antibiotics especially Penicillin which is 
predominantly used in the prevention and treatment of mastitis in the farm where the current 
study was conducted without prior antibacterial sensitivity test. 
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5.1. Introduction 
Mastitis is a complex disease generally common in dairy animals. Several causative agents 
are known to be involved in mastitis infection (Awale et al., 2012). The heavy financial 
burden caused by mastitis disease on farmers and to the dairy sector as a whole is enormous 
(Sawant et al., 2009). Mastitis has become a global issue due to its adverse effects on cow 
health, milk quality and milk production level of cows (Seegers et al., 2003; Awandkar et al., 
2009; Sharma et al., 2011). The disease can be transferred from an infected cow to a health 
cow causing increase in intra mammary infections if herds are not properly managed 
(Tremblay et al., 2013). Like other major mastitis causing organism, Staphylococcus aureus 
is a well-known bacterial organism that causes mastitis in cows (Heringstad et al., 2000). But, 
unlike Staphylococcus aureus, CNS is usually reported to play an insignificant role in the 
cause of mastitis in cows (Sawant et al., 2009).  
 
Technically in mastitis diagnosis, Staphylococcus species are grouped into Coagulase 
Positive Staphylococci and Coagulase Negative Staphylococci based on their ability to 
coagulate rabbit plasma (Addis et al., 2011). Staphylococcus aureus is a Coagulase Positive 
Staphylococcus and has been well reported in literature to be a major mastitis causing 
pathogen (Bradley, 2002; Fergusson et al., 2007). But, on the contrary CNS is commonly 
reported as a minor mastitis causing pathogen (Heringstad et al., 2000; Lim et al., 2007). 
However, recent findings in several nations of the world including South Africa have 
indicated CNS as a significance mastitis causing agent (Wilson et al., 1997; Ferguson et al., 
2007; Petzer et al., 2009; Addis et al., 2011; Kenar et al., 2012; Kateete et al., 2013). They 
are frequently isolated from milk of cows with clinical and subclinical mastitis and have been 
linked to cause mastitis in dairy cows (Sampimon et al., 2009; Oliveira et al., 2013). 
 98 
 
 
The result observed from Chapter 3 gave evidence to the fact that several Staphylococcus 
species could be involved in the cause of mastitis in a dairy farm. However, there could be 
differences in the incidence of Staphylococcus species and their antimicrobial sensitivity to 
conventional antibiotic from different dairy farms due to different management systems 
adopted by different farms and also due to differences in farm location. Information on the 
variation of species specific bacterial organisms linked with mastitis and their antimicrobial 
sensitivity to antibiotics (in different farms) would assist farmers in implementing effective 
mastitis control and therapy on their farms.  
 
Modern invention of milking practices has reduced the prevalence of several major mastitis 
causing organisms including Staphylococcus aureus and Streptococcus agalactiae in dairy 
farms (Makovec and Ruegg, 2003). Some studies conducted recently in the United States 
indicated a widespread of environmental micro-organisms including CNS to be the major 
cause of clinical mastitis in farms (Lago et al., 2011; Pinzon-Sanchez and Ruegg, 2011; 
Schukken et al., 2011). Akin to Staphylococcus aureus, CNS can also cause persistent intra 
mammary infections for a long period of time in cows if not checked (Gillespie et al., 2009). 
Mastitis caused by CNS is mostly prevalent in a farm that has successfully managed the 
spread of mastitis disease caused by major mastitis causing organisms (Gillespie et al., 2009). 
Coagulase negative staphylococci are known to be a peculiar problem in such farms (Myllys 
and Rautala, 1995).  
 
In most dairy farms today mastitis disease is considered to be a major reason for the use of 
antibiotics (Roesch et al., 2006; Awandkar et al., 2009). This is because farmers are involved 
in the indiscriminate use of antibiotics without carrying out in vitro sensitivity tests leading to 
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repeated failure in mastitis control and therapy of dairy animals (Kaliwal et al., 2011). The 
continual use of antibiotics has led to the evolution of antibiotic resistance genes by 
Staphylococcus species and increases in financial losses due to the treatment of affected 
animals (Awandkar et al., 2009). Staphylococcus aureus and CNS are among the bacterial 
species that are often resistant to several antibiotics used on farms (Tenhagen et al., 2006; 
Pyorala and Taponen, 2009). To achieve a worthwhile result that can be implemented for 
effective control of mastitis, bacterial identification and their antibiotic resistance pattern is of 
high necessity (Kaliwal et al., 2011). In view of this, the current study was undertaken to 
identify and also to determine the antibiogram trend of some selected antibiotics to some 
Staphylococcus species isolated from milk samples of cows with subclinical mastitis in a 
commercial dairy farm located in the Eastern Cape of South Africa. 
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5.2. Materials and methods 
5.2.1. Study site and milk sample collection 
The study was conducted in a commercial dairy farm in Eastern Cape, South Africa. Isolates 
(n= 62) from 250 milk samples were derived from a collection of 11 different Staphylococcus 
species. Milk samples were collected in a 10 ml sterile bottle from lactating cows for nine 
months from March to November, 2012. After the milk samples were collected they were 
promptly kept in cooler boxes containing ice before transporting them to the laboratory for 
microbial analysis. 
 
5.2.2. Bacterial isolation and identification  
Milk samples were screened following the procedures recommended by the National Mastitis 
Council (NMC). In brief, composite foremilk samples collected from individual cows were 
streaked in Mannitol salt agar that was prepared within 24 hours and incubated for 24-48 
hours for bacteria growth. Mannitol salt agar was prepared according to manufacturers’ 
instructions. Presumed isolates of Staphylococcus species gave a yellow fermentation in 
Mannitol salt agar.  
 
5.2.2.1. Sub-culturing of milk samples in nutrient agar 
Presumed isolates that gave a positive result in Mannitol salt agar were sub-cultured again in 
a freshly prepared nutrient agar (within 24 hours) and they were then placed in an incubator 
for 24 hours. This is done so as to get a pure colony of the bacteria isolate. 
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5.2.2.2. Gram’s staining test 
All presumed cultures of Staphylococcus species were subjected to gram’s stain. Few 
colonies of pure cultured isolates were aseptically picked from the nutrient agar and then 
smeared on a sterile glass slide. The smeared culture was heat fixed to dryness. Crystal violet 
(0.5%) was added to the smear and left for I minute. Water was used to wash off the stain 
from the slide. Sufficient solution of iodine was again added to the smear and left for I 
minute. Water was used to wash off the stain. Ethanol (95%) was afterward used to rinse the 
stain from the slide. Safrani solution was finally added to the smear for 2 minutes before 
being washed with water. The smear was allowed to dry for a few minutes before they were 
viewed under a light microscope to determine the colony structure of the bacteria species. 
The smear of each bacteria species was viewed under x10, x40 and x100 magnification. 
Gram’s stain smears that were positive gave a grape-like clustered shape with deep blue to 
purple colour.  
 
5.2.2.3. Oxidase test 
Few colonies of isolates from nutrient agar from presumed Staphylococcus species were 
picked aseptically using a sterile loop and then placed on an oxidase test strip paper. All 
isolates that turned purple on the test strip paper after 10 seconds were suspected to be 
Staphylococcus species. 
 
5.2.2.4. Catalase test 
Pure cultures of presumed Staphylococcus species from nutrient agar were aseptically 
transferred onto a clean glass slide. Few drops of 3% H2O2 were then added to the cultures. 
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Positive cultures of Staphylococcus species gave out bubbles of oxygen within 5 seconds 
after adding H2O2. 
 
5.2.2.5. API
®
 Staph kit test for identification of Staphylococcus species 
All presumed isolates were finally confirmed to their species level using the API
®
 staph kit 
(bioMerieux, France). Homogeneous Inoculums of pure cultured isolates were prepared with 
turbidity equivalent to 0.5 McFarland using the API
®
 Staph medium. Pipette was used to fill 
the micro tubes of the API kit with the inoculated API Staph medium. Mineral oil was added 
to the arginine dehydrolase (ADH) and urease (URE) tests to ensure anaerobiosis. The 
incubation box of the API kit was filled with 5mls of distilled water and closed tightly before 
incubating at 37
0
C for 24hrs. After incubation one drop of API Staph reagent was added to 
the inoculated micro tubes to determine their reactions. The reactions of the inocula were 
read using the apiweb 
TM
 identification software (bioMerieux, Inc Quebec).  
 
5.2.3. Minimum Inhibitory Concentration (MIC) determination 
Isolates that were identified to their species level were subjected to in-vitro drug sensitivity 
test using the discs diffusion method as postulated by the Clinical Laboratory Standard 
Institution (CLSI, 2006). Briefly, a few colonies of isolates were aseptically inoculated in 
normal saline to the desired turbidity (0.5 McFarland standards). With the aid of a sterile 
cotton swab, the inocula were evenly spread on Muller-Hinton agar in a petri dish. The 
antibiotic discs were then gently pressed on the agar and placed in an incubator for 24 hours 
at 37
o
 C. The MIC of each isolate was afterward determined by measuring (in millimetres) 
the zones of inhibition in the Mueller Hinton agar with a metre rule so as to obtain the 
diameter of inhibition of the different isolates. Among the antibiotics used were 
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Levofloxacin, Ciprofloxacin, Kanamycin, Meropenem, Ofloxacin, Tetracycline, Gentamicin, 
Erythromycin, Imipenem, Chlorofenicol, Nalidixic acid, Amoxicillin, Penicillin and 
Vancomycin. 
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5.3. Results 
Results from the current study showed that a total of 62 (24.8%) isolates were identified from 
an aggregate of 250 milk samples which were examined from subclinical mastitis cows. 
Table 5.1 shows the prevalence of the 11 different Staphylococcus species that were 
identified. In vitro antibiogram studies were conducted for the 62 isolates that were 
identified. The result revealed Imipenem to be the most effective drug (98.4%) against the 
bacterial isolates followed by Gentamycin (95.2%), Tetracycline (90.3%) and Meropenem 
(88.7%), (Table 5.2). The lowest sensitivity was observed for Erythromycin (30.6%) 
followed by Penicillin (32.3%), Nalidixic acid (33.9%) and Vancomycin (59.7%). Examining 
individual Staphylococcus species (Staphylococcus aureus and CNS), Staphylococcus aureus 
was 100% resistant to Penicillin, Staphylococcus capitis was 100% resistant to Nalidixic acid 
and Penicillin, Staphylococcus cohnii-cohnii was 100% resistant to Ciprofloxacin, 
Erythromycin, Nalidixic acid, Penicillin and Vancomycin while  Staphylococcus 
haemolyticus gave 100% resistance to Erythromycin and Penicillin. 
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Table 5. 1 Prevalence of Staphylococcus aureus and CNS isolated from bovine milk. 
Staphylococcus species Number of isolated species (%) 
S. aureus 8 (12.90) 
S. hominis 6 (9.67) 
S. warneri 4 (6.45) 
S. xylosus 20 (32.25) 
S. sciuri 4 (6.45) 
S. lentus 3 (4.83) 
S. chromogenes 3 (4.83) 
S. saprophyticus 10 (16.12) 
S. capitis 1 (1.61) 
S. cohnii-cohnii 1 (1.61) 
S. haemolyticus 2 (3.22) 
Total 62 (100) 
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Table 5. 2 Antimicrobial susceptibility of S. aureus and CNS isolated from bovine milk (%).  
Staphylococcus Spp N CIP LEV OFX MEM E NAL IMI VA PG GM T K AMO C 
S. aureus 8 4(50) 7(87.5) 4(50) 8(100) 3(37.5) 1(12.5) 7(87.5) 6(75) 0 8(100) 8(100) 8(100) 7(87.5) 6(75) 
S. hominis 6 6(100) 6(100) 6(100) 6(100) 3(50) 2(33.3) 6(100) 6(100) 3(50) 6(100) 5(83.3) 6(100) 6(100) 6(100) 
S. warneri 4 4(100) 4(100) 4(100) 4(100) 2(50) 2(50) 4(100) 4(100) 4(100) 4(100) 4(100) 2(50) 4(100) 4(100) 
S. xylosus 20 16(80) 15(75) 16(80) 19(95) 3(15) 6(37.5) 20(100) 11(55) 3(15) 19(95) 17(85) 17(85) 11(55) 17(85) 
S. sciuri 4 1(25) 4(100) 4(100) 2(50) 1(25) 2(50) 4(100) 3(75) 1(25) 4(100) 4(100) 2(50) 3(75) 4(100) 
S. lentus 3 2(66.7) 2(66.7) 2(66.7) 3(100) 1(33.3) 1(33.3) 3(100) 1(33.3) 3(100) 3(100) 3(100) 3(100) 3(100) 3(100) 
S. chromogenes 3 3(100) 3(100) 3(100) 3(100) 2(66.7) 2(66.7) 3(100) 1(33.3) 3(100) 3(100) 3(100) 3(100) 3(100) 3(100) 
S. saprophyticus 10 8(80) 10(100) 10(100) 7(70) 3(30) 4(40) 10(100) 3(30) 3(30) 8(80) 8(80) 8(80) 7(70) 8(80) 
S. capitis 1 1(100) 1(100) 1(100) 1(100) 1(100) 0 1(100) 1(100) 0 1(100) 1(100) 1(100) 1(100) 1(100) 
S. cohnii-cohnii 1 0 1(100) 1(100) 1(100) 0 0 1(100) 0 0 1(100) 1(100) 1(100) 1(100) 1(100) 
S. haemolyticus 2 2(100) 2(100) 2(100) 1(100) 0 1(50) 2(100) 1(50) 0 2(100) 2(100) 2(100) 2(100) 1(50) 
Total (%) 62 47(75.8) 55(88.7) 53(85.5) 55(88.7) 19(30.6) 21(33.87) 61(98.4) 37(59.7) 20(32.3) 59(95.2) 56(90.3) 53(85.5) 48(77.4) 54(87.1) 
N:  Number of isolates, CIP: Ciprofloxacin, LEV: Levofloxacin, OFX: Ofloxacin, MEM: Meropenem, E: Erythromycin, NAL: Nalidixic, IMI: 
Imipenem, VA: Vancomycin, PG: Penicillin-G, GM: Gentamycin, T: Tetracycline, K: Kanamycin, AMO: Amoxicillin, C: Chlorofenicol.
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5.4. Discussion 
The prevalence of both Staphylococcus aureus and CNS in sub-clinical and/or clinical 
mastitis may pose a serious threat to cows in a dairy herd (Wilson et al., 1997; Tremblay et 
al., 2013). Though, CNS is often reported as a group (Addis et al., 2011), several different 
species exist among them (Sawant et al., 2009). It is therefore needful to discuss the 
individual species differently due to the variation that exist in their clinical significance as 
mastitis pathogens (Piessens et al., 2011; Supre et al., 2011).  
 
The findings of the current study showed the highest incidence of Staphylococcus species to 
be Staphylococcus xylosus (32.25%) followed by Staphylococcus saprophyticus (16.12%) 
and Staphylococcus aureus (12.90%). Both Staphylococcus xylosus and Staphylococcus 
aureus have been indicated to show more adhesive ability to their host cells (Rohde et al., 
2007; Tremblay et al., 2013), which may be the reason for their high incidence in the farm. 
Studies have shown that some Staphylococcus species possess the ability to adhere and also 
to invade their host cells (udder) than others in a process known as biofilm formation; this 
plays an important role to their prevalence in milk of cows (Rohde et al., 2007; Kaliwal et al., 
2011). In addition, Staphylococcus xylosus is known to be a free-living opportunistic 
bacterium that could easily find its way into the udder of cows (Gillespie et al., 2009). 
Clinical mastitis could result from subclinical mastitis due to persistent incidence of CNS in a 
farm (Gillespie et al., 2009). The least frequently isolated CNS species from the current study 
include Staphylococcus capitis (1.61%), Staphylococcus cohnii-cohnii (1.61%) and 
Staphylococcus haemolyticus (3.22%). This was similar to the study of Kenar et al. (2012) 
that observed the least frequently isolated organisms from milk to be Staphylococcus capitis 
(1.4%), Staphylococcus cohnii-cohnii (2.9%) and Staphylococcus haemolyticus (4.4%), 
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respectively. The CNS that were least isolated could be because they are not well adapted to 
the udder of the cow (Kaliwal et al., 2011).   
 
In another study by Gillespie et al. (2009), Staphylococcus haemolyticus was indicated to be 
least commonly isolated from milk samples. Also, Matthews et al. (1990) in their study 
reported Staphylococcus haemolyticus and Staphylococcus cohnii-cohnii to be the least 
frequently isolated organisms from milk samples. Contrary to our findings, other studies 
indicated Staphylococcus chromogenes and Staphylococcus hyicus as the most commonly 
isolated CNS species from milk samples (Trinidad et al., 1990; Taponen et al., 2006; Sawant 
et al., 2009). The high prevalence of Staphylococcus xylosus and Staphylococcus aureus 
could be linked to a poor level of hygiene in the farm (Harmon, 1993; Sharma et al., 2011). 
 
The antibiotic sensitivity tests carried in the current study showed that there was resistance of 
some Staphylococcus species against one or more antibiotics. Imipenem (98.4%), 
Gentamycin (95.2%), Tetracycline (90.3%), Chlorofenicol (87.1%), Levofloxacin (88.7%), 
Ofloxacin (85.5%), Kanamycin (85.5%) and Amoxicillin (77.4%) were observed to be very 
effective on most of the species isolates. In another study by Zahid (2004), it was observed 
that Gentamycin, Tetracycline, Chlorofenicol, Kanamycin and Amoxicillin were highly 
effective against most bacterial isolates that cause mastitis. All the isolates of Staphylococcus 
aureus were resistant to Penicillin. Most of the isolates of Staphylococcus aureus were also 
observed to be resistant to Nalidixic acid and Erythromycin but susceptible to Tetracycline, 
Ofloxacin and Ciprofloxacin. Sharma et al. (2011) in their study also observed similar 
resistance of Staphylococcus aureus to Nalidixic acid and Erythromycin but observed a high 
susceptibility to Tetracycline, Ofloxacin and Ciprofloxacin. Antibiotics such as Gentamycin, 
Ciprofloxacin and Chlorofenicol among others are new antimicrobial agents introduced into 
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the market for treating mastitis cows (Sumathi et al., 2008). This could be the reason for their 
effectiveness against the mastitis pathogens in the current study. Mekuria et al. (2013) in their 
study observed high resistance of Staphylococcus aureus to Penicillin but resistance to 
Chlorofenicol, Gentamycin and Vancomycin was negligible. This is in agreement with the 
current study. According to Sumathi et al. (2008), Penicillin resistant bacteria produce certain 
enzymes (plasmids mediated beta lactamase) that make them resistant against antibiotics. 
 
Erythromycin was observed to be effective against most CNS species isolates except for 
Staphylococcus cohnii- cohnii and Staphylococcus haemolyticus. In a study by Sawant et al. 
(2009), Erythromycin was effective against most CNS species. Kaliwal et al. (2011) also 
indicated in their study that antibiotics including Ciprofloxacin, Erythromycin, Gentamycin 
and Amoxicillin were effective against several CNS species but, Penicillin was not. Their 
finding is in line with the present study. Mohanty et al. (2013) observed that Chlorofenicol, 
Levofloxacin and Ciprofloxacin were effective against several Staphylococcus species apart 
from Penicillin that was not effective. This is similar to the current findings. On the other 
hand, Roesch et al. (2006) indicated in their study that most CNS species isolated from milk 
(in an integrated dairy production farm) were resistant to Erythromycin. Variation exists in 
the effectiveness of antibiotic against individual CNS species which could in turn affect their 
prevalence in a farm as a result of difference in antimicrobial recommendation by farmers 
which vary in different areas (Kenar et al., 2012).  
 
Though information about how long Penicillin have been consistently used in the farm is not 
known, arbitrary use of the drug in the farm of the current study could be the reason for the 
resistance of several species isolates to the antibiotics (Awandkar et al., 2009; Sharma et al., 
2011). Another possible reason could be that antibiotics administered to animals for treatment 
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of mastitis may be less in terms of dosage than the recommended dose making the drug 
ineffective as was observed during the few visits to the farm hence causing microbial 
resistance build up (Malinowski et al., 2002). According to (Rajala-Schultz et al., 2009), 
acquisition of new resistant genes and chromosome mutations by previously susceptible 
strain of Staphylococcus species could also be other reason for antibiotic failure of a 
particular antibiotic. 
 
5.5. Conclusion 
The findings from the current study revealed differences in antimicrobial sensitivity patterns 
among Staphylococcus species. Imipenem was observed to be the most effective antibiotic 
against the isolated bacterial species while Penicillin was the least effective antimicrobial 
agent. This may be as a result of the frequent use of Penicillin for mastitis treatment in the 
farm. 
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Chapter 6: General Discussion, Conclusions and Recommendations 
6.1. General discussion 
The objective of the study was to determine the incidence of Staphylococcus species 
distribution in bovine milk of cows with subclinical mastitis in commercial dairy farms and to 
determine their sensitivity to conventional antibiotics and U. barbata extracts. The incidence 
of Staphylococcus species and their antibiotic sensitivity pattern was determined in Chapter 3 
and Chapter 5. In Chapter 3, association of some possible risk factor variables such as stage 
of lactation, parity number and time of year milk samples were examined was also tested 
against the incidence of Staphylococcus species in milk. In Chapter 4, the in-vitro inhibitory 
activity of U. barbata extracts (methanol and ethyl-acetate) against selected Staphylococcus 
species was determined. 
 
In Chapter 3 and 5, the incidence of Staphylococcus species was observed through the 
sampling period. The most prevalent Staphylococcus species that were isolated from milk 
samples in Chapter 3 include Staphylococcus xylosus (22.09%), Staphylococcus hominis 
(15.11%) and Staphylococcus haemolyticus (11.63%). While the most prevalent 
Staphylococcus species isolated from the farm in Chapter 5 include Staphylococcus xylosus 
(32.25%), Staphylococcus saprophyticus (16.12%). The prevalence of these Staphylococcus 
species maybe a result of the heavy infestation of these bacteria in the surrounding 
environment of the farm (Bendahou et al., 2008; Piessens et al., 2012; Ayano et al., 2013).  
Opportunistic Staphylococcus species including Staphylococcus xylosus, Staphylococcus 
hominis and Staphylococcus haemolyticus from the udder or milking clusters often find their 
way into the mammary gland of cow udders during milking if the hygiene at the farm is poor 
(Schukken et al., 2009). 
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In Chapter 3, the prevalence of Staphylococcus species isolated in milk varied with the time 
of the year milk was sampled. In the hot-dry season of the year, it was observed that the 
incidence of Staphylococcus species was higher as compared with the other seasons. Climatic 
variation which may have affected the population of some bacterial species could be the 
reason for our observation (Piessens et al., 2012; Sampimon et al., 2011). There was a 
significant association (p= 0.0039) between the incidence of Staphylococcus species and the 
stage of lactation that was observed in Chapter 3. The level of cleanliness of cows at different 
stages of lactation may vary, which could have been attributed to our observation (Abera et 
al., 2010). 
 
High resistance of Staphylococcus species was observed for Penicillin, Ampicillin and 
Nalidixic acid in Chapter 3. Resistance to Penicillin and Ampicillin by several 
Staphylococcus species in Chapter 3 could a result of frequent use of the antibiotics in the 
farm. Penicillin is one of the mostly used antibiotics in the farms where this study was 
conducted. According to Awandkar et al. (2009) and Sharma et al. (2011), indiscriminate use 
of the same antibiotic to treat mastitis disease in cows could lead to the development of a 
resistant strain against the drug by the causative pathogen. 
 
In Chapter 4, there was significant activity of the U. barbata extracts against several 
Staphylococcus species including Staphylococcus xylosus, Staphylococcus sciuri, 
Staphylococcus lentus and Staphylococcus epidermidis with zone of inhibition ranging from 
13 to 34 mm. With reference to ≥ 11mm, about half of the total Staphylococcus species were 
susceptible to U. barbata extracts. Nyenje and Ndip (2011), proposed a minimum of ≥ 11 
mm of zone of inhibition of plant extracts tested against micro bacteria in-vitro to be deemed 
effective. The sensitivity of methanol and ethyl-acetate extracts at 5mg/ml against all tested 
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organisms gave a susceptibility of 92.31% and 53%, respectively of all test organisms. The 
inhibitory ability of the lichen extract against the isolated organisms could be due to the 
presence of bioactive compounds such as flavonoids, tannins, atranorin, lignins, phenolic 
acid, usnic acid, norstictic acid and chloroatranorin in them (Rankovic et al., 2012; 
Wendakoon et al., 2012).  
6.2. Conclusion 
There was relatively high incidence of Staphylococcus species isolated from milk samples of 
cows with subclinical mastitis from both farms where the study was conducted. Differences 
existed in the sensitivity of different Staphylococcus species to various antibiotics. From the 
antibiotic susceptibility result observed in the current study most Staphylococcus species 
were resistant to Penicillin and Ampicillin. Methanol and ethyl-acetate extracts of U. barbata 
exhibited in-vitro inhibitory activities against selected Staphylococcus species which indicate 
its potential as a medicinal plant. 
6.3. Recommendations 
The extracts from U. barbata lichen showed a potential attribute, in-vitro, as antimicrobial 
agents against Staphylococcus species linked with the cause of mastitis disease in cows. It 
could be recommended that they could be useful for the treatment of animals with mastitis 
disease. 
Areas that require further research: 
 The virulence level of individual specific Staphylococcus species as mastitis pathogen 
in cows. 
 The active ingredients in the South African ecotype of U. barbata lichens responsible 
for the inhibitory effect of Staphylococcus species. 
 The effect of the U. barbata extracts on mastitis cows in-vivo. 
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 The dosage of U. barbata extracts that will be effective against mastitis bacteria.  
 The detrimental effect of the Staphylococcus species isolated from raw milk on 
human safety.  
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